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ABSTRACT
A DISTINCT PATTERN OF STERILE INFLAMMATION INDUCED BY ZINC
OXIDE NANOWIRES

Ruqaih Salem Alghsham

August 2, 2019
In recent years, there has been an increasing interest in nanotechnology.
Engineered nanomaterials (ENMs) become an increasingly important area in
nanotechnology. Recent developments in ENMs have drawn commercial and
research attention in many areas such as agriculture, medicine, and Industry.
High-aspect ratio zinc oxide nanowires (ZnONWs) have become one of the most
significant ENMs due to their remarkable physical properties which makes them
useful in a wide-range of applications. However, questions have been raised
about ZnONW safety uses and biological consequences.
In this dissertation, we investigated the inflammatory potential of ZnONWs
in mouse models. C57BL/6 mice were exposed to ZnONW via intra-tracheal
route. Two days post-instillation, the broncho-alveolar lavage fluid (BALF) was
analyzed for inflammatory cells and for presence of pro-inflammatory cytokines.
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We found that the intratracheal instillation of ZnONW in C57BL/6 mice induced a
significant increase in the total numbers of immune cells in BALFs two days after
instillation. Macrophages and eosinophils were the predominant cellular infiltrates
of ZnONW-exposed mouse lungs. In an air-pouch mouse model that simulates
local exposure to ZnONW, similar cellular infiltrates were observed. Analysis of
lavage fluids revealed that pro-inflammatory cytokines IL-6 and TNF-α as well as
chemokines CCL11 and CCL2 were increased both in BALFs and air-pouch
lavage fluids. The cellular basis of inflammatory mediators that were induced by
ZnONW were investigated in cultured cells. ZnONW exposure induced both IL-6
and TNF-α production only in macrophages but not in lung epithelial cells
(LKR13). Exposure of macrophages to ZnONW induced the production of CCL11
only while LKR13 cells induced both CCL11 and CCL2. Confocal microscopy
showed rapid phagocytic uptake of FITC-ZnONW aggregates by macrophages.
The phagocytosis of ZnONW particles is essential for the production of both IL-6
and TNF-α. These results suggest that exposure to ZnONW may induce distinct
inflammatory mediators through phagocytic uptake.
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CHAPTER 1
INTRODUCTION
Engineered nanomaterials (ENMs)
Material with a one or more dimensional shape in the size range from 1 to 100
nanometers (nm) are referred to as nanomaterials [1, 2]. There are two types of
nanomaterials: naturally occurring nanoparticles, which are also referred to as
ultrafine nanoparticles, and engineered nanoparticles (ENPs). The naturally
occurring nanoparticles include volcanic ash soot from forest fires or diesel
engines [3-6]. These naturally occurring nanomaterials are usually physically and
chemically heterogeneous [7]. On the other hand, engineered nano-materials
(ENMs) are created by the manipulation of matter at the nano-scale to produce new
materials and structures [8, 9]. A myriad of new ENMs are being rapidly developed and
introduced into many different sectors, such as commerce, agriculture, and medicine [1012].
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ENMs are designed with very specific properties related to chemistry,
shape, size, and surface area. Their novel physicochemical properties facilitate
wide-range of applications in consumer products, such as food additives,
batteries, cosmetics, drug delivery system, and sunscreens [12].

ENMs are

being produced in large-scale quantities, thereby posing unknown environmental,
human, and occupational exposure hazards. The tiny size and light weight of
these ENMs make control, such as filtration or dampening, difficult.
Types of engineered nanomaterials

There are different types of ENMs exist; however, for the purpose of this
dissertation, the focus is on two types of ENMs: metal-based ENMs and carbonbased ENMs. Metal-based ENMs are defined by particles that are made of metal
precursors while carbon-based ENMs contain predominantly carbon atoms that
are arranged in a unique way.
Commonly used ENMs
 Metal-based ENMs


Silicon dioxide nanoparticles (SiONP): SiONP is the main component
for the manufacturing of several consumer products, such as glass,
paints, plastics, cosmetics, food additives, and rubber [13, 14].



Titanium oxide nanoparticles (TiONP): TiONP has applications in the
manufacturing of cosmetics, food, and sunscreen products. The unique
properties and the size of TiONPs allow them to form a protective layer
on the skin without being completely absorbed [13].
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Zinc oxide nanoparticles (ZnONP): With the significant advancement
in the alternative energy market, ZnONP has become one of the
leading metal oxide ENMs used in electronics, optical devices. ZnONP
is also used in battery storage due to its photocatalytic activity [15].



Aluminum oxide nanoparticles (AlONP): AlONP is commonly used in
making cement, paints, and aircrafts.
 Carbon-based ENMs



Graphene: Graphene is a nanomaterial composed of an allotropic, twodimensional hexagonal structure of carbon atoms, which was first
described in the 1970s; however, nano-scale graphene was introduced
in 2004 with different structures, such as single layers, nanotubes, and
fibers. Recently, graphene has become a promising nanomaterial for
many bio-technological applications, in the field of environmental
engineering and biomedicine [16].



Single or multi-walled carbon nanotubes (CNTs): CNTs are derived
from graphene, which is considered one of the oldest and most widely
used natural nanomaterial. CNTs are used in many applications, such
as biomedical and electronic devices [17, 18].

ENMs market dynamics

In 2015, the global market for nanotechnology was predicted to grow and
to employ up to two million workers [19]. By 2022, the anticipated benefits from
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the ENMs market will be $55 Billion (Fig1) [20]. The US and Japan have over a
half of the world’s demand for ENMs. The U.S. leads the global market and the
recent developments in the field of ENMs by 46%, especially in the global health
sector [20]. Hence, in the U.S. alone, 800,000 workers face a high probability for
occupational exposure hazards to ENMs [21]. According to Nanowerk, there are
more than 1,000 consumer products containing ENMs. Approximately 2,500
commercial ENMs are used, that including 27% metal oxide nanoparticles, such
as ZnONP and SiONP [.http://www.nanowerk.com/ phpscripts/ndbsearch.php].
The growing production of ENMs has raised concerns related to their potential
effects on the environment and biological health. In addition, ENMs are
synthesized in and with varying shapes, sizes, coatings, surface charges, and
surface areas, which makes both biological and environmental potential hazards
unpredictable. Hence, the biological and environmental impacts of ENMs must
be determined.
Dynamics of the global nanomaterials demand by regions bases is
listed below from the highest to the lower demand
• North America includes the U.S., Canada, and Mexico.
• Europe includes the UK, Germany, France, and Italy.
• The Asian Pacific region includes China, India, and Japan.
• Central and South America (Brazil).
• The Middle East includes Saudi Arabia and Turkey.
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Figure 1: The ENMs market growth from the base year 2010 to 2022 in
terms of revenue (USD billion) [20].
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The environmental and biological impacts of ENMs
In the past two decades, nano-toxicology has become a highly important
field in science due to an increase in the utilization of ENMs. This has increased
the need for studying the potential side effects of ENMs in biological and
ecological systems, which will ultimately contribute to understanding and
generating rules and safety measurements when using and synthesizing ENMs.
In this section, the implications of ENMs for environmental and biological
systems are discussed.
The environmental impacts
Without doubt, the volume of ENMs released into the environment will
increase due to the widespread use of products containing ENMs either during
manufacture, transport, use, or disposal [22]. Consequently, the entire
environmental compartment will be affected. The eco-toxicological effects of
ENMs are not well-defined and require further investigation [23] for several
reasons. First, the current data on the actual volume release of ENMs and the
accumulated concentration into the environment are poorly understood and
limited [24-26]. This is because the lack of data on the production volumes of
ENMs creates a fundamental obstacle to future investigations into their release
[27, 28]. Another challenge is that different ENMs accumulate at different sizes
and rates in the environment depending on the variable abiotic factors in the
environment (pH soil, ionic composition, and soil texture), which leads to
differences in eco-toxicological outcomes. Furthermore, there is a lack of suitable
tools, analytical approaches, and methods to study the environmental impact of

6

ENMs. Another important question that needs to be addressed is what is the fate
of the end-of-life product of ENMs and their proper safe disposal methods?
Therefore, there is a compelling need to study and to investigate the actual
release and distributions of ENMs in the environment to better understand their
impacts [29-32]. Previous studies have shown that soluble metal oxide ENMs,
such as TiO2 and ZnO, might accumulate in environmental components (soils,
soil’s organisms, and freshwater) as particulates in concentrations that exceed
the sub-toxic levels [27, 33-35]. Furthermore, some metal oxide materials, such
as TiO2 and ZnO, which are essential elements in many consumer products,
have antimicrobial properties that may pose a direct or indirect impact, triggering
alterations in the ecosystem, including fish, bacteria, and plants [36]. Table 1
presents the environmental concentrations of some ENMs in three main
pathways into the environment.
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ENMs

Surface water

WWTP Sludge

WWTP Waste and
Sewage

ZnONP

1−10 000 ng/L

13.6−64.7 mg/kg,

0.22−1.42 μg/L,

TiONP

21−10 000 ng/L

100−2000 mg/kg

1−100 μg/L

CNP

0.001−0.8 ng/L

0.0093−0.147

3.69−32.66 ng/L

mg/kg
AgNP

0.088−10 000 ng/L

1.29−39 mg/kg

0.0164−17 μg/L

Table 1: Predicted environmental concentrations of highly used ENMs in three
main pathways into the environment (modified and reproduced from Ref [37]).
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The biological impacts
The potential consequences of ENMs on biological systems strongly
depend on the physical and chemical properties as well as the route of exposure
[38]. Several studies have reported the toxicity of ENMs in both in vitro and in
vivo experimental models [39-52]; however, the biological effects of many of the
ENMs are not well-defined. The small sizes of ENMs allow them to infiltrate
epithelial barriers, causing their accumulation and deposition into vital organs
and tissues, including the kidneys, heart, and liver [53-57]. In addition, some
forms of ENMs may cross blood-brain barriers, leading to brain damage and
neurological side effects [55]. Furthermore, studies have shown that exposure to
ENMs via several routes, such as inhalation, ingestion, or dermal contact, could
lead to a variety of disorders, such as myocardial infarction, stroke, thrombosis
caused by platelet enhanced aggregation by ENMs [58-60], and lung injury or
inflammation [61, 62]. Moreover, at the cellular level, ENMs may induce cell
death, mitochondrial damages, and genotoxicity (DNA damage and mutation)
[53, 63, 64]. The leakage of ENMs ions from their core may elicit biological
consequences, especially if the metal ion released has biological and
physiological functions. Earlier studies have suggested that the production of
reactive oxygen species (ROS) and free radicals are the underlying mechanisms
of ENMs cytotoxicity. Cell death and cell damage could result from ROS or
ENMs’ physical damage of cell membranes. In addition to oxidative stress,
inflammation, DNA damage, and apoptosis have also been suggested to be
mechanisms of ENMs toxicity [65-71]. Other proposed mechanisms in which
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ENMs induce toxicity have been suggested, such as the disruption of intracellular
transport and cell division, a disturbance in DNA transcription, mitochondrial
damage and dysfunction, and lysosomal destabilization, leading to autophagy
and cell death [72]. Moreover, genotoxicity is one of the biological side effects of
ENMs exposure, and ENMs genotoxicity is defined by the damage of the
intracellular DNA that could result from direct ENM interactions with DNA or
indirect interactions via ROS production after ENM exposure; however, long-term
secondary adverse effects, such as chronic respiratory distress syndrome, of
ENMs are overlooked and require further investigation.
OSHA’s exposure limit recommendations
• Respirable carbon nanotubes and carbon nanofibers should not exceed
1.0 (μg/m3) as an eight-hour time-weighted average (TWA).
• TiONPs (particle size less than 100 nm) should not exceed 0.3 (mg/m3).
• TiONPs (particle size greater than 100 nm) should be 2.4 mg/m3.
OSHA’s permissible exposure limits to zinc oxide fumes
•

5 mg/m3 (TWA).

• 10 mg/m3 short-term exposure limit (STEL).
Exposure limits for other nanomaterials do not exist yet.
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ENMs

Oxidative stress

DNA damage

Apoptosis and
cell death

Inflammation

Figure 2: The schematic model illustrates the mechanisms in which ENM
induces cytotoxicity: ENMs induce ROS generation, which leads to oxidative
stress. Oxidative stress could either be induced cell death or DNA damage that
could lead to an inflammatory response. ENMs could also prompt inflammation
through damage-associated molecular patterns (DAMP).
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Factors influence ENMs toxicity
The physicochemical properties of ENMs, including dissolution, size,
shape, chemical composition, surface area, and charge, influence the biologicalinteraction of ENMs. Thus, for a complete understanding of the biological impacts
of ENMs, it is important to evaluate the physicochemical properties of ENMs and
to understand the interaction between these properties to determine the toxic
potential of ENMs in the biological system. There are underlying factors that
contribute to ENMs toxicity: size, shape, surface area, charge, and chemical
composition.
Size
Size is an important factor that determines the effective interaction
mechanism between ENMs and biological systems, especially the immune
system. It has been suggested that the smaller the particles, the more
toxic they are [73]. ENMs with a size less than 20 nm can easily traverse
through epithelium and endothelium barriers and enter cells. The small
size of ENMs, which is similar to the size of spheroproteins (2-10 nm), not
only enable their translocation through cellular membranes but also allows
them to enter the nuclei and other cell organelles [74]. According to Huo et
al., six nm gold NPs were found in the nucleus, while 16 nm gold NPs
were only found in the cytoplasm [75]. Furthermore, size controls the
recognition, uptake, and clearance of ENMs by immune cells, such as
macrophages. ENMs with a size less than five nm enter the cell
membrane via nonspecific transport mechanisms, whereas 10 to 25 nm
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ENMs are taken up by immune cells through pinocytosis. Larger particles
are believed to be prime for the phagocytosis mechanisms, such as
micropinocytosis [76, 77]. Due to the small size, ENMs of 5-10 nm will be
not cleared effectively by immune cells, which leads to the accumulation
and translocation of ENMs in vital organs [78-80]. Aggregation and
agglomeration also contribute to the size and toxicity of ENMs. Once
ENMs interact with biological media, they can aggregate or agglomerate1,
which can influence the particle size and can lead to different biological
effects.
Shape
ENMs have different shapes, such as spheres, sheets, cubes, rods,
and ellipsoids. The shape as well as the aspect ratio are the two essential
elements that influence the toxicity of ENMs. Several studies have
investigated shape-dependent toxicity [81-84]. According to Holian et al.,
the clearance of TiONPs, either spherical or nano-belts, was affected by
particle shape after pulmonary lung exposure in mice. TiONP spheres
were cleared more effectively than TiONP nano-belts [85]. Moreover, rodlike or needle-like ENMs induced more cell death and damage compared
to spherical ENMs [86]. Overall, shape controls the uptake and clearance
of ENMs by phagocytes and could lead to cell death and damage.
_____________________________________________________________________________
1Aggregation

is different from agglomeration: aggregation cannot be reversible under any certain
conditions, while in agglomeration, under some chemical/biological conditions, the release of the
actual primary individual particles is possible [21].
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Surface area and charge
ENMs are characterized by a large surface area, which provide them
with a high reaction capacity and a high catalytic activity compared to
micro-particle of the same material. Because the first interactions between
ENMs and biological systems begin at the surface of the ENMs, the
surface area plays a role in toxicity. The smaller the size, the more surface
area they have and the higher toxicity [73]. The surface charge
significantly contributes to the toxicity of ENMs [87, 88]. Surface charges
affects the interaction and translocation of ENMs. Positively charged
ENMs were found to be more toxic than negative or neutral ENMs [89].
The electrostatic attraction between the negative charges of the cell
membrane (glycoprotein) and the positive charge of ENMs allows them to
enter the cell easily compared to neutral or negatively charged ENMs [90].
Moreover, positively charged ENMs adsorb protein more efficiently than
those with a negative charge. The adsorption with serum protein and other
proteins allows ENMs to form a protein corona. This formation has a direct
effect on the uptake and recognition of ENMs by immune cells [91].

Chemical composition
Particle chemistry is a crucial aspect of cell molecular mechanisms
and oxidative stress. The chemical stability of ENMs is affected by the
environmental conditions inside the cells, e.g., the pH level. Therefore,
chemical composition is another factor that affects ENMs toxicity. Some
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ENMs, such as ZnONP, is known to have a high dissolution rate with a low
pH [92]. Although Zn and other metal ions have biological benefits for the
cell, studies have shown that ZnONP induces toxicity and cell death due
to the dissolution of ZnONP inside the acidic vacuoles of cells, leading to
an increase in the Zn ions inside the cells [92]. The type of metal also
contributes to the toxicity and has different toxic effects. A comparison
study was performed to study the toxicity effect of SiONPs and ZnONP.
SiONP induce toxicity by altering the DNA structure of the cells, whereas
toxicity induced by ZnONP is caused by the production of ROS and
oxidative stress [93], indicating that particle chemical composition played a
primary role in the cytotoxic function.
In summary, shape, size, chemical composition, surface charge, and area
are major factors that determine and influence the toxicity of ENMs; however,
other factors must be investigated, such as coating and surface roughness.
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Sterile inflammation
The immune system plays a vital role in host defense against intrusion,
including by pathogens, through the process of inflammation. For microbial
infections, an inflammatory cascade promotes the recruitment and activation of
innate immune cells, such as macrophages and neutrophils [94]. These cells
have a role-clearing microbe though phagocytosis and the production of proinflammatory cytokines and chemokines to activate an adaptive immune
response. Inflammation can also be triggered in response to non-microbial
agents. This type of inflammation is known as sterile inflammation, which is an
inflammation triggered by pathogen-free agents, such as physical, chemical, or
metabolic insults, including environmental particles, such as asbestos and silicon
dioxide crystals [94, 95]. Sterile inflammation is considered one of the underlying
factors that lead to many inflammatory diseases. ENMs, such as metal-oxide and
carbon-based nanoparticles, may initiate sterile inflammation [96]. Similar to
pathogen-induced inflammation, ENMs may prompt sterile inflammation and may
induce the recruitment of inflammatory cells, such as macrophages and
neutrophils, and the production of pro-inflammatory cytokines because they can
function as danger signals (DAMP) [96]. The inflammation cascade may be
induced by damage-associated molecular patterns (DAMP) [97]; Previous
studies reported that ENMs promote the secretion of chromatin associates
protein high-mobility group box-1 (HMGB-1) which considered as highly active
danger signal that initiate inflammatory cascade [98]. However, the process of
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inflammation induced by ENMs is not fully understood, and the possible
biological consequences of ENMs-induced sterile inflammation requires further
investigation [96]. Table 2 provides a list of in vitro studies that investigated the
signaling pathway of sterile nanoparticles-induced sterile inflammation. [96, 99103].
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Type of
nanomaterial
MWCNT

Cell type
A549 lung epithelial
cells

TiO2-NP

Human intestinal
epithelial cells,
human epithelial,
colorectal
adenocarcinoma
Caco-2 cells, and
THP1macrophages

SiONP

Murine bone
marrow-derived
dendritic cells,
murine bone
marrow derived
macrophages,
human
macrophage cell
lineTHP1,
and primary human
keratinocytes
Macrophages and
A549 cells

ZnO-NP

Signaling pathways

Biological effect

NLRP-3
inflammasome
activation

Activation of the
inflammasome
–caspase-1 related
pathway leading to
ILβ and IL-18
release
NLRP-3
Exposure to TiO2inflammasome
NPs induces
activation
NLRP-3ASC-caspase-1
assembly and
caspase1cleavage;
The activation of
NLRP-3 complex
causes the release
of functionally
active IL-1β.
NLRP-3
Induced caspase-1
inflammasome cleavage and IL-1β
activation
secretion via the
NLRP-3
inflammasome

NF-kB;
NLRP-3
inflammasome
activation

Activation of the
inflammasome –
caspase-1 related
pathway leading to
IL-β and IL-18
release.

Table 2: In vitro studies that investigated the signaling pathway of sterile nanoparticles induced inflammation.
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Zinc oxide nanoparticle (ZnONP)
ZnONP applications
Zinc oxide nanoparticles (ZnONP) have become one of the most important
and promising metal oxide nanoparticles that are commonly used in many
different areas due to their unique physical and chemical properties [104, 105].
ZnONP have been used in many industrial products. In 2015, worldwide
production was estimated to be about one million tons per year. The rubber
industry was the first known to use ZnONP based on their waterproof function
and enhancement of the performance of high polymers in rubber [106, 107].
Later, due to ZnONP’ UV absorption properties, they were used in many
personal consumer products, such as cosmetics and sunscreen [108]. Moreover,
ZnO has an antimicrobial activity, and thus ZnONP is commonly used as food
additives as well as in the textile industry and for deodorants and antibacterial
products [109]. ZnONP has a promising application in the field of electro, opto,
and photo technology, electronic/electrical devices, and batteries [110-112].
Apart from these applications, ZnONP have attracted considerable attention in
the medical field and are used in drug delivery systems and anticancer
treatments, and they have the potential to enhance other drugs’ activities, such
as insulin [110, 113, 114]. The tremendous increase in production and the use of
ZnONP poses a large risk of exposure to both the public and workers, who could
be exposed through different routes, such as ingestion, inhalation, or skin contact
[21]; however, the biological effect of ZnONP remains controversial in recent
studies. Previous studies have shown that ZnONP has anti-inflammatory
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properties due to the suppression of the mRNA expression of many inflammatory
cytokines, such as IL-1β and TNF-α [115-121]. Moreover, the U.S. Food and
Drug Administration (FDA) categorized the use of ZnO in micron sizes as safe,
“GRAS” (generally recognized as safe), for use as food additives but not ZnONP.
On the other hand, many other studies have suggested that ZnONP indeed
exhibit inflammatory potential both in vivo and in vitro.
Potential exposure hazards and side effects of ZnONP
It has been known for some time that metal fume fever syndrome is
caused by the inhalation of ZnO fumes among foundry workers [122-125].
Exposure to ZnONP may also lead to health complication. Consequently, there is
a need for an evaluation of the health consequences of ZnONP exposure.
ZnONP could be recognized by the immune system as danger signals.
Consequently, inflammatory responses to ZnONP could lead to a wide range of
disorders. Several studies have demonstrated that ZnONP have the ability to
induce toxicity both in vivo and in vitro.

In vitro toxicity of ZnONP
Extensive studies have investigated the toxicity effect of ZnONP in
different cell lines.
Production of reactive oxygen species (ROS)
ROS is formed as a result of mitochondrial oxidative metabolism
and cellular responses to bacterial infections. It is composed of different
oxidative species, which include superoxide anion, hydrogen peroxide,
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singlet oxygen, and hydroxyl radicals. ROS is known for its regulatory role
in cell signaling and homeostasis [126]. There are two types of sources
that induce ROS formation within the cells: endogenous and exogenous.
Mitochondrial respiration and inflammatory responses are some of
endogenous sources for ROS generation, while bacterial invasion,
pollution, and ENMs act as exogenous sources. Several studies have
shown that ZnONP induce a substantial increase in the ROS level in vitro
after ZnONP exposure [127-131]. Thus, ROS production leads to oxidative
stress and mitochondrial damage [132].
Oxidative stress
Upon ZnONP exposure, the intracellular levels of ROS increases.
This triggers the enzymatic and non-enzymatic antioxidant system in cells.
When the antioxidant system in the cell is exhausted, the cells fail to
reduce the intracellular ROS level, leading to ROS accumulation and a
disturbance in the cellular homeostasis. As a result, oxidative stress
occurs. Oxidative stress contributes to cell damage, mitochondrial
damage, and autophagy [132-137].
Another cellular response to ZnONP is the production of proinflammatory cytokines. The interaction of ENMs with cell surface
receptors leads to the activation of intracellular signaling pathways.
According to Roy et al., Toll-like receptor 6 (TLR6) mediates the
inflammatory responses of ZnONP in peritoneal macrophages [138]. The
production of pro-inflammatory cytokines, such as IL-8 and TNF-α, is
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mediated through the activation and upregulation of inflammatory
pathways, including nuclear factor kappa-light-chain enhancer of activated
Bcells (NF-κβ), mitogen-activated protein kinase (MAPK), and other
pathways involved in Myeloid differentiation primary response 88 (myD88)
[139-141].
Genotoxicity
Genotoxicity is a potential biological response to ZnONP exposure.
It has been shown that high doses of ZnONP leads to cellular toxicity and
cell death; however, the effect of a low dose of ZnONP exposure has been
overlooked. Low doses of ZnONP could lead to genetic alterations,
causing DNA damage [142-145]. According to Heim et al., ZnONP
induces a DNA double strand break [146]. These genetic alterations could
lead to mutations and carcinogenesis. The genotoxicity of ZnONP was
investigated in kidney epithelial cells and other cell types [147]. ZnONP
induces DNA damage due to an increase in ROS generation, which
results from an increase in intracellular Zn2+ ion concentrations. ZnONP
also induces dysregulation in cardiac functions and vascular homeostasis.
Intra-tracheal instillation of ZnONP to Wistar rats induced systemic
inflammation, dyslipidemia, increase levels of serum biomarkers of
atherosclerogenesis (heme oxygenase-1 [HO-1] and platelet endothelial
cell adhesion molecules-1 ,and aortic pathological damage [148].
The underlying factor that leads to ZnONP toxicity is the solubility of
ZnONP in the acidic vacuole of the cells, such as phagolysosome. This leads to
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an increase in the intracellular Zn2+ ions concentration [149-152]. The Zn2+ ion is
an essential element in many biological reactions. It is important for enzyme
activity and many nuclear proteins, such as zinc finger nucleases [113].

In vivo ZnONP toxicity
Several studies have investigated the toxicological effect of ZnONP in vivo
[153-156]. The intra-tracheal instillation of ZnONP in mice induced acute lung
inflammation and lung injury with a significant increase in the LDH level detected
in bronchial alveolar lavage fluids (BALF) [157, 158]. Moreover, ZnONP induced
the recruitment of macrophages and neutrophils with high levels of proinflammatory cytokines, such as IL-6 in BALF, after pulmonary exposure in mice
[159-161]. Furthermore, ZnONP appears to have an adjuvant-like response to
allergen ovalbumin (OVA) and induce Th2 responses in mice [154]. Oral
exposure to ZnONP in rats for five days revealed significant hepatic damage and
severe nephrotoxicity [162, 163]. According to Attia et al., neurotoxicity in rats
was observed after oral exposure to ZnONP resulting in oxidative stress and
genotoxicity, inflammation, and apoptosis [133]. In addition, a study conducted
with human volunteers showed that the inhalation of ZnONP induces flu-like
symptoms and a significant increase in serum amyloid A (SAA), and two acute
phase proteins C-reactive protein (CRP) [164]. It has been suggested that the
toxicity of ZnONP in vivo is similar to the in vitro finding of the solubility of ZnONP
in the acidic pH of cell vacuoles [165]; however, a study conducted by Xia et al.
showed that dietary ZnONP improved intestinal microbiota and inflammation
responses in weaned piglets [166].
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ZnONP and the innate immune cells
The innate immune system (nonspecific) is the first line of defense against
foreign insults, including ENMs. The interaction of ENMs with innate immune
cells may induce an immunomodulatory response either by the activation or the
suppression of the innate immune system (Fig3) [98, 167]. The key mechanism
of the innate immune system is the process of phagocytosis. Phagocytic cells,
such as macrophages, and other phagocyte cells mediate the phagocytosis
process through pattern recognition receptors (PRPs) on phagocytic cells, (e.g.
toll-like receptors (TLR)), that recognize a wide variety of pathogens’ molecular
patterns referred to as pathogen-associated molecular patterns (PAMPs) such as
lipopolysaccharides (LPS) on the bacterial cell wall [168]. Similarly, macrophages
could recognize ENMs. ENMs may interfere with It has been suggested that
ENMs may serve as DAMP signals that could induce innate immune reactions
[96].Several studies have shown that ZnONP induces the activation and
recruitment of innate immune cells upon exposure either in vitro or in vivo
correspondingly.

Macrophages and ZnONP
Macrophages are the first responders to danger signals. They are
professional phagocytic cells that mediate recognition and phagocytosis via
different reporters, including scavenger receptors (SR), mannose receptors (MR),
and complement receptors (CR) [169]. Furthermore, receptors on macrophage
such as TLRs play a vital role in the early recognition of ZnONP and
subsequently induce a pro-inflammatory response [141, 170]. According to Roy
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et al., the inflammatory responses of activated macrophages triggered by ZnONP
depend on TLR6, which induces the expression of genes involved in
inflammation. Briefly, ZnONP promoted the expression of CD1d, MHC-II, CD86,
and CD71, which are activation and maturation markers, on macrophages as
well as the production of pro-inflammatory cytokines, such as IL-6, IL-1β, and
TNF-α. The production of these pro-inflammatory cytokines was suppressed after
inhibiting MAPKs pathways and TLR6 signaling using siRNA [138]. Moreover, the
downstream signaling of TLRs mediates the activation of many inflammatory
pathways, such as MAPK, ERK1/2, JNK, p38, and NF-κB. The activation of these
pathways leads to the production of pro-inflammatory cytokines and chemokines
by the recruitment of a specific set of adaptor molecules, such as MyD88 and
TRIF [171]. It has been suggested that ZnONP induces inflammatory responses
through the activation of MyD88, NF-κB, and MAPK [139]. Furthermore, the
activation of TLR signaling not only induces inflammation and the production of
pro-inflammatory cytokines but also increases the phagocytosis process by
macrophages such as TLR6 [169].
Macrophages have the ability to infiltrate tissues during inflammation
[172]. Alveolar macrophages play a major role in the onset and progression of
pulmonary diseases, such as asthma, chronic obstructive pulmonary disease
(COPD), and pulmonary fibrosis [173]. Because inhalation is the common
exposure route of ZnONP, alveolar macrophages are one of the first cells to
come in contact with ZnONP in the lungs [159, 174]. The interaction between
these cells and ZnONP is not well-understood. Some researchers have proposed
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that the interaction between alveolar macrophages and ZnONP is mediated by
non-specific binding, and some believe that it is mediated via scavenger
receptors, such as the B1 scavenger receptor [134]. Moreover, ZnONP inhalation
in mice infected with Haemophilus influenza (NTHi) reduced the bacterial
clearance in BALF and in lung tissues by impairing alveolar macrophage
activation [175].

Lung epithelial cells and ZnONP
Lung epithelial cells play an important role in immune responses upon
ZnONP exposure. In vitro, ZnONP exhibited the highest toxicity to lung epithelial
cells compared to other ENMs, such as TiO2, CeO2, and Al2O3NP [176]. The
toxicity was linked to oxidative stress and DNA damage after ZnONP exposure
[177, 178]. According to Wu et al., ZnONP induced IL-8 expression in bronchial
epithelial cells through the phosphorylation of the proteins p65 and IkB-α, which
are both part of the NF-КB signaling pathway [140]. A previous study showed that
challenged mice with ZnONP after ovalbumin (OVA) administration, lead to
induce Th2 responses in the lungs. These results indicated that ZnONP could act
as adjuvants to OVA, [179].

Eosinophils
Eosinophils were first discovered in 1879 by Paul Ehrlich. Eosinophils
account for around 3% of the leukocyte sub-population in human circulation with
a half-life ranging from 8-18 hours, while in the tissues, the half-life could extend
up to six days [180]. Eosinophils are characterized by a distinctive dark pink
intracellular granule in standard hematoxylin and eosin (H&E) staining.
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Eosinophils’ granules contain hydrolytic enzymes, such as the major basic
protein (MBP), eosinophil peroxidase (EPO), eosinophil-derived neurotoxin
(EDN), and cationic granule proteins [181]. Moreover, it has been acknowledged
that eosinophilic granules not only contain hydrolytic enzymes but also contain
various cytokines and chemokines. These pre-made cytokines and chemokines
have many diverse biological functions and are available for rapid release upon
stimulation [182-184]. Initially, it was believed that eosinophils only play a major
role in controlling parasitic infections (helminth) and are involved in allergy
diseases, such as asthma [185-188]. Later, eosinophils’ functions were found to
be involved in many physiological processes, such as organ development [189,
190], tissue repair and degradation [191-193], maintaining and recruiting
lymphocytes [194-196], anti-microbial activity [197-199], fungal immunity [200,
201], and tumor immunity [202].
Previous studies have suggested that ZnONP may promote eosinophilic
airway inflammation in rodents. In OVA, challenged mice models, ZnONP
exposure was found to increase the eosinophilic inflammation in the broncho
alveolar lavage fluid (BALF) at seven days after oropharyngeal aspiration [154].
In another study, the intra-tracheal instillation of ZnONP induced the recruitment
of eosinophils in the alveolar interstitium in C57BL/6 mice [153]. In contrast,
according to Silva et al., ZnONP provides anti-apoptotic properties to human
eosinophils by preventing caspase activation and Bcl-xL degradation, leading to
delayed human eosinophils apoptosis [203]. In addition, ZnONP did not induce
the production of ROS in human eosinophils [203].
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Cellular mediators induced by ZnONP (cytokines and chemokines)

Interlukins-6 (IL-6) and Tumor necrosis factor alpha (TNF-α)
For most acute inflammatory conditions, both IL-6 and TNF-α are
elevated. IL-6 induces fever reactions, while TNF-α promotes hypertension
through endothelia cell activation [204]. Furthermore, IL-6 and TNF-α activate
immune cells and are involved in the progression of many inflammatory
diseases, such as rheumatoid arthritis [205]. IL-6 is a cytokine involved in many
physiological processes, such as inflammation, infection, and regulation of
metabolic, regenerative, and neural processes [206]. TNF-α is a pleotropic
cytokine with diverse biological functions, including acute and chronic
inflammation and the regulation of cell growth and proliferation [207]. As
mentioned above, ZnONP induce toxicity in the cells via oxidative stress. The
overwhelming oxidative stress response by the cells promotes the activation of
several signaling pathways, such as MAPK and NF-κB, triggering cell signaling
cascades that lead to an increase in cytokine expression, such as interleukins
and TNF-𝛼 [208]. Several studies showed that ZnONP exposure induces the
production of IL-6 and TNF-α both in vivo and in vitro [123, 138, 178, 209, 210].
Once ZnONP are engulfed by macrophages or exposed to epithelial cells, a
variety of pro-inflammatory cytokines, such as IL-6 and TNF-α, and chemokines,
such as CCL2, CCL3, CXCL1, and CCL11, are secreted; however, the exact
sequence of the events that occur in these cells that result in the production of
these cytokines/chemokines is not defined.
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Monocyte chemoattractant protein 1
Monocyte chemoattractant protein 1(MCP-1), also known as CCL2, is a
potent macrophage chemoattractant involved in the polarization and recruitment
of murine macrophages during inflammation [211]. Previous data suggest that
elevated levels of CCL2 are linked to chronic inflammatory diseases, such as
obesity associated-type 2 diabetes and cardiovascular diseases [212, 213].
Regarding ZnONP exposure, earlier studies reported a significant increase in
CCL2 levels after ZnONP exposure either in vivo (lung) or in vitro [158, 179,
214]. According to Sahu et al., ZnONP promote the expression of the MCP-1
mRNA level in THP-1 cells in vitro after exposure [215]. Moreover, in Balb/c
mice, exposure to ZnONPs induced the production of CCL2 in lung, leading to a
T helper cell (Th2) response.

Eotaxin (CCL11)
Eotaxin (CCL11) is an eosinophils chemoattractant that was first defined
in the BALF of OVA-sensitized guinea pigs to promote eosinophils recruitment
[216]. In asthma and animal pulmonary allergic inflammation models, there is a
positive correlation between the number of eosinophils recruited to the lungs and
the local CCL11 level [217-220]. As stated, ZnONP promotes lung inflammation
and induce the accumulation of eosinophils in BALF or the alveolar interstitium in
rodent inflammation models with or without OVA sensitization, respectively.
Saptarshi et al. reported the upregulation of CCL11 mRNA in the lung tissue after
ZnONP exposure in mice. Furthermore, the CCL11 level was significantly
elevated in BALF within 24 hours of ZnONPs exposure in mice [153, 221].
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Figure 3: Schematic model illustrating ENMs inducing an immunomodulatory
response in the innate immune system: ENMs could induce an innate immune
response by a direct interaction with innate immune cells, such as macrophage
and mast cells, or by recruiting the innate immune cells to the site of exposure
through cellular mediators, such as through cytokines and cell-specific
chemokines, leading to the recruitment of more immune cells, such as
neutrophils, basophiles, and eosinophils. Figure adopted from [95].
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Zinc oxide nanowires (ZnONWs)
Zinc oxide nanowires (ZnONWs) with a one-dimensional (1D) shape have
recently been synthesized by Advanced Energy Materials, LLC. (Fig 4). They
have developed novel vapor-phase methods for generating these nanowires,
which have numerous potential industrial applications; however, finite information
is available regarding the potential biological effects of these novel nanowires.
ZnONW share the same chemical composition as the commercial spherical
ZnONP, which induce toxicity both in vivo and in vitro. The toxicity is mainly due
to the solubility of ZnO particles in the acidic pH inside the phagolysosomal
compartment of the cell. On the other hand, the change in the physical form of
ZnONW to 1D may elicit different biological responses, especially an immune
response [38, 92]. In addition, there are other ENMs that have a 1D shape, such
as a carbon nanotube (CNT). Carbon nanotubes have been widely used in many
areas such as biomedical and electronic devices [18, 19]. Due to the unique 1D
shape and small size of CNT, it has been linked to many pulmonary diseases,
such as lung fibrosis and asthma [222]. According to Rydman et al., CNTs induce
inflammation in mice lungs by recruiting macrophages and eosinophils [223].
Furthermore, CNTs lead to inflammation and progressive fibrosis on the parietal
pleura in mice. The cellular mechanism of CNTs inducing inflammation is ROS
generation, which leads to activation in AP-1, NF-𝜅B, p38, and Akt signaling
pathways [68]. Due to the large-scale production and increasing utilization of
ZnONWs, concerns regarding ZnONW toxicity and whether ZnONWs are safe
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are increasing. Thus, it would be highly beneficial to study and to investigate the
safety of these ZnONWs.

Figure 4: Scan electron microscopy (SEM) image of ZnONWs (left);
transmission electron microscopy (TEM) of ZnONWs (right).
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Significance and Aim of the study
ZnONW has become one of the most important products in optical and
electronic applications. They are being produced in large-scale quantities using
different methods, such as vapor-phase, solution-phase, and hydrothermal
methods, which could lead to occupational health risks. The potential exposure
routes of these ZnONWs may vary depending on both occupational and
environmental exposure. Human exposure to ZnONW and under acidic
conditions in the cells (ZnO has a sensitive dissolution point) eventually trigger
the release of Zn ions within the cells, leading to cell toxicity and death.
Therefore, for this dissertation, the biological effect of ZnONW was assessed.
First, the way such cellular and molecular responses are integrated into an
inflammatory response in mouse models was determined. In addition, the cell
types involved in the production of pro-inflammatory cytokines and chemokines
were delineated. Therefore, the specific aims were as follows.

AIM I: Investigate the potential of ZnONW to induce sterile inflammation in
a mouse model. The large-scale production and ZnONW may lead to
environmental pollution which increased risk of human exposure to ZnONW.
Since the common exposure routes for these particles are skin contact, and lung,
the inflammatory response in the following models. The consequences of
local/systemic inflammatory responses to ZnONW were investigated.
Because the common exposure routes for these particles are skin contact
(local) and inhalation, the inflammatory responses in the following models were
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examined. First, local inflammation in the air pouch was used as a skin exposure
model. Second, to simulate airway exposure, lung inflammation following the
intra-tracheal instillation of ZnONW was analyzed. Lavage fluids were analyzed
for inflammatory infiltrates as well as cytokines and chemokines were measured
to identify the cellular mediators responsible for inducing inflammation.

AIM II: Defining the cellular mediators and cell types activated by ZnONW
exposure.
The specific pathways that could lead to the sterile inflammation in vitro
were assessed. Previous studies showed that macrophage-specific (CCL2) and
eosinophil-specific (CCL11) chemokines and TNF-α and IL-6 cytokines are
induced upon ZnONP exposure, and because ZnONW share the same chemical
composition of ZnONP, it was important to explore whether ZnONW induce the
production of these chemokines and cytokines as well as to investigate the
cellular and molecular basis for the production of these cytokines and
chemokines by ZnONW. Using murine primary macrophages (BMDM),
macrophage cell lines (RAW-264.7 cells), and lung epithelial cell lines (LKR-13),
ZnONW was exposed to these cell lines, and the chemokine and cytokine
production in culture supernatants was determined. The results were further
confirmed using the qRT-PCR. Next to investigate the cellular uptake of ZnONW
in BMDMs cells, FITC labeled ZnONWs were generated. Confocal microscopy,
various staining techniques and pharmacological inhibitors were used to define
the cellular uptake of ZnONW. Lastly, In-vitro toxicity experiments were
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performed in bone marrow-derived macrophages, RAW-264.7, and LKR13 cells
to evaluate the cell viability upon ZnONW exposure.
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Figure 5: Schematic model of ZnONWs-induced sterile inflammation: ZnONWs
induce inflammation in the lungs and the Air-pouch by recruiting immune cells,
such as macrophages and eosinophils. The inflammatory exudates contain IL-6,
TNF-α, CXC, and CCL. The cell types responsible for the production of these
chemokines and cytokines and the pathways need to be identified.
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CHAPTER 2
MATERIALS AND METHODS

Nanoparticles and Reagents
Zinc Oxide nanoparticles ZnONPs (10-30 nm) and ZnONWs (100 nm)
were provided by Advanced Energy Materials, LLC, a nanowire powder
manufacturing company in Louisville, KY. Silicon dioxide nanoparticles
(SiO2NPs 7nm &200 nm) was obtained from sigma Aldrich. All particles were
made

endotoxin-free

by

baking

at

200°C

overnight.

The

following

pharmacological inhibitors were used in the study: Cytocholasin D, (from SigmaAldrich) Bafilomycin-A1 (Santa Cruz). E.coli, LPS (LPS-EK; InvivoGen).
Mice
C57BL/6 mice were purchased from Jackson laboratories and bred at the
University of Louisville. All mice were used in ex-vivo and in-vivo experiments
were sex and age matched 6-8 weeks. All mice were maintained in a specific
pathogen free facility and cared for in accordance with the institutional and
National Institutes of Health (NIH) guidelines. The University of Louisville
Institutional Animal Care and Use Committee (IACUC) approved all the
procedures.
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Fluorescein isothiocyanate (FITC) labeling of ZnONWs
Four

mg

of

ZnONWs

were

dispersed

in

3

ml

anhydrous

dimethylformamide (DMF). Then a diluted solution of 0.5 μl of amino-propyltriethoxy-silane (APTS) in 25 μl DMF was added to the ZnONWs suspensions,
which was followed by sonication, and stirring under nitrogen at room
temperature for 20 h. ZnONWs were collected by centrifugation and removing
the supernatant. After washing, ZnONWs were re-suspended in 0.5 ml DMF and
mixed with a solution of 1 mg FITC and 0.5 ml DMF. The suspension was stirred
for 4 h, and the FITC-labeled ZnONWs were collected by centrifugation. FITClabeled. ZnONWs were thoroughly washed with DMF, dried under vacuum and
stored as dry powders [224].

Bone marrow derived macrophages
Six to eight-week-old C57BL/6 mice were euthanized by using CO2. The
hind legs were dissected and the bone marrow cells were flushed out with cold
Dulbeco’s Modified Eagle Medium (DMEM). The bone marrow cells were
cultured in DMEM containing 10% FBS,100 units/ml penicillin, 100 mg/ml
streptomycin, 2 mM L-glutamine and 50 mM β -mercaptoethanol supplemented
with 25 ng/ml recombinant mouse macrophage colony stimulating factor
(BioLegend; San Diego, CA). The cells were plated at a density of 1 million cells
per 100-mm tissue culture dishes containing 10 ml of medium. After 3 days, 10
ml of fresh growth medium was added to replace the medium. The cells were
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maintained for another 3 days before the experiments. The purity of the cells
(>99%) was confirmed using flow cytometry by surface staining for F4/80 and
CD11b.

Cell culture
Raw 264.7, mouse macrophage cell line (American Type Culture
Collection (ATCC), Manassas, VA, USA) and LKR13 cells, murine K-ras mutant
lung adenocarcinoma cell line were maintained in Dulbecco’s Modified Eagle’s
Medium (DMEM; Hyclone Laboratories, Inc., South Logan, UT, USA)
supplemented with 10% heat-activated fetal bovine serum (FBS, Hyclone
Laboratories Inc.) and 100 units/ml penicillin, 100 μg/ml streptomycin, 2 μM LGlutamine and 50 μM β - mercaptoethanol (Gibco®, Invitrogen Corporation,
Carlsbad, CA, USA) at 37°C in a 5% CO2 incubator. Cells were seeded at
0.5x106 cells/ well density into six well plates.

In vitro ZnONWs, ZnONP and SiONP Stimulation Assay

BMDMs were plated at a density of 0.5x106 cells per well in a six well
culture dish in 2 ml of DMEM containing 10% FBS and allowed to attach
overnight. BMDMs were primed with or without 10 ng/ml of LPS (LPS-EK;
InvivoGen, San Diego, CA) for 3 hours. Cells were washed with pre-wormed
PBS three times. Then the media was changed to 1% FBS media with final
volume of 1000µl in 6 well plate. The cells were then pre-treated with or
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without t h e

pharmacological inhibitors Baf-A1 or CytD at the indicated

concentrations for 1 hour prior to stimulation with 10 o r 20 µg/ml of particles
f o r 3-6 hours.
RAW 264.7 cells were plated at a density of 0.5x 106 cells per well in a six
well culture dish in 2 ml of Hyclone DMEM containing 10% FBS and allowed to
attach overnight. The cells were primed with or without 10 ng/ml of LPS for 3
hours. Cells were washed 3 times with pre-wormed PBS. Then the media was
changed to 1% FBS media with final volume of 1000 µl in 6 well plate. The cells
were then treated with 10 or 20 µg/ml of particles for 6-18 hours.

LKR13 cells were plated at a density of 0.5 x106 cells per well in a six well
culture plate in 2 ml of Hyclone DMEM containing 10% FBS and allowed to
attach overnight. Cells were washed 3 times with pre-wormed PBS. Then the
media was changed to 1% FBS media with final volume of 1000 µl in 6 well
plate. The cells were then treated with 10 or 20 µg/ml of particles for 6 hours.

Enzyme-Linked Immunosorbent Assay (ELISA)
IL-6, TNF-α and IL-1β in the cell culture supernatants were measured
using mouse IL-6, TNF-α and IL-1β ELISA MAX Standard Kit (Biolegend). LTB4
in the cell culture supernatants was measured using LTB4 EIA Kit (Cayman
Chemicals). Briefly, Polyvinyl chloride (PVC) microtiter plates were coated with
anti-cytokine antibody overnight at 4°C. The next day, the plates were washed
using washing buffer, and non-specific binding blocked using blocking buffer
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provided by the manufacturer. The standard dilution and the required dilutions
were made for the following step. Cell culture supernatants were added to the
coated plates, and plates were incubated for 2 hours at room temperature. The
secondary antibodies (detection antibody) for IL-6, IL-1β and TNFα were added
to the respective plates. Then plates were washed. The assay was developed
according to the manufacturer’s instruction and the intensity of the signal was
detected using ELISA plate reader at recommended wavelength (405 nm for IL6, TNF-α, or IL-1β and at 450nm for LTB4). The data was calculated by
extrapolating the absorbance of each protein (cytokine) and the standard curve.

RT-PCR Assay
Cells (BMDMS, RAW 264.7 and LKR13) were lysed using TRIzol reagent
and total RNA was isolated using an RNeasy Mini Kit (Qiagen) using
manufacturer’s protocol. RNA samples were treated with DNase (Qiagen) to
remove any trace of DNA from the samples before reverse transcription with
TaqMan reverse transcription reagents (Applied Biosystems) using random
hexamer primers. Quantitative PCR was performed using ‘power SYBR-green
master mix’ Applied Biosystems). Expression of the target genes was
normalized to GAPDH and the relative fold changes relative to the PBS were
calculated using the delta delta CT method. Data were representative of
triplicate cell cultures. GAPDH, CXCL1, CXCL2, CCL2, CCL3, CCL4, CCL5,
CCL11, TNFα and IL-6 primers obtained from Real Time Primers.
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MTT assay
The MTT assay is a colorimetric assay for assessing cell metabolic
activity. BMDM, LKR13 and RAW264.7 cells were treated with ZnONWs for
different time points 2, 4, 6, 18 hours. Then 3-[4, 5-dimethyltiazol-2-yl] 2, 5diphenyl-tetrazolium bromide (MTT) was added to the cells at the end of each
time point. After 2h incubation with MTT, DMSO was added for 10 min.
absorbance was measured at 562 nm using a BioTek microplate reader.

Immunofluorescence
BMDMs cells (0.7x106 ) were plated in a 35 mm cover-glass bottom dish
(World precision Instruments, Sarasota, FL) in DMEM with 10% FBS and grown
overnight. The media was changed to DMEM with 1% FBS and the cells were
primed with 10ng/ml LPS for 3 hours. Then cells were treated with 1μM Baf-A1
for 1h. Then cells were stimulated with 25 µg/ml FITC ZnONW for 3hrs. next
cells were washed 3X with PBS and fixed with 10% formalin for 15 min. after
fixation, cells were washed three times with 1X PBS, cells were stained with
1:500 dilution 594-Cholera toxin Subunit B and 1:1000 dilution DAPI
(ThermoFisher Scientific) and washed again before analyzing with confocal
microscopy. The confocal images were captured using Nikon A1R confocal
microscope at 60 x magnification with appropriate lasers as indicated. A
minimum of five to six fields were captured for each sample.
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Acridine orange staining
Acridine orange is a fluorescence dye that is easily crosses the cell
membrane. It used to stain acidic vacuoles (lysosomes, endosomes, and
phagolysosome), with red to orange color and RNA, and DNA with green color in
living cells. BMDMs were treated with or without Baf-A1 for one hour followed by
FITC-ZnONWs. Next cells were washed and loaded with 5 µg/ml acridine orange
(Sigma- Aldrich) for 30 minutes. Cells were washed with Hank's balanced salt
solution (HBSS) before imaging using confocal microscopy.

Antibody staining
BMDMs were treated with 1Μm BafA-1 for 1 hour followed by 25μg/ml
FITC-ZnONWs treatment for 3 hours. Then, cells were fixed with 10% formalin
for 15 min and permeabilized with 0.1% saponin. Non-specific binding was
blocked using with 1% BSA for 1 hour. Next, cells were incubated with LAMP-1
antibodies (a rat anti-mouse (1D4B) (abcam) at 1:500 dilution overnight at 40C.
Later, cells were washed three times with 1X PBS and followed by an Alexa 594labeled secondary (rat anti-mouse IgG A-11032: ThermoFisher Scientific) at
1:500 dilution for 1-2 hours. Cells were washed three times with 1X PBS and
stained with DAPI. Cells were washed with HBSS before imaging by confocal
microscopy.
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Air pouch experiment
Five ml of sterile air was injected into the back of mice subcutaneously to
generate an air pouch. Three days later another 3 ml of sterile air was injected
into the pouch to maintain the air-pouch. After 3 days, 2 mg of particles in 500 μl
of endotoxin-free PBS was injected into the air pouch. Control animals received
500 μl of endotoxin-free PBS. After 6 hours of injection, mice were euthanized
and the air pouch was lavaged with 3 ml of cold PBS.

Particles installation in mouse lungs
Mice were treated with antibiotics for one-week prior to surgery. Mice
were surgically instilled (intratracheal) with endotoxin-free PBS (negative control)
or 0.67 mg of endotoxin-free SiONPs (positive control) or 0.67mg of ZnONWs
suspended in endotoxin-free PBS. Previous studies have reported the use of 0.2
μg/mouse [225] and 0.168 μg/mouse of ZnONPs [226]. Particles suspension
was vortexed before instillation to avoid settling of the particles. Mice were
continuously maintained on antibiotics until euthanasia two days after instillation.
Lungs were lavaged with 2 ml of cold PBS and BALF were obtained.
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Flow Cytometry
Cells from air-pouch and BALFs were stained with various cell surface
marker antibodies from BD Biosciences (San Diego, CA) or Biolegend (San
Diego, CA). Data were acquired on FACS Calibur or FACS Canto (BD
Biosciences) and analyzed using Flowjo software (Tree Star). Leukocytes were
identified as CD45+ cells, lung macrophages as CD45+ FSChi CD11chi F4/80+
cells, neutrophils as CD45+ CD11c− Ly6Ghi Siglec-F− cells, eosinophil as
CD11b, CD193, F4/80, Siglec-F, B cells as CD45+ FSClo B220+ cells, CD4 cells
as CD45+ FSClo CD4+ and CD8 cells as CD45+ FSClo CD8+. In air-pouch
lavage fluids, leukocytes were identified as CD45+ cells, macrophages as
CD45+ FSChi F4/80+ CD11bhi Ly6Glocells and neutrophils as CD45+ SSChi
Ly6Ghicells, eosinophil as CD11b, CD193, F4/80, and Siglec-F.

Cytospin
The cytospin is a high speed centrifuge to concentrate the cells in a
sample on a slide. It used to analyze the cell morphology and type. The air
pouch lavage fluid cells and BALFs cells were spun down using Shandon
Cytospin centrifuge (Shandon Lipshaw) followed by staining with Hema-3
reagents

(ThermoFisher

Scientific)

according

recommendations.
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Multiplex analysis
Lung lavage fluids and Air-pouch lavage from PBS or particles treated
mice were measured for various levels of inflammatory proteins including TNF-α,
CXCL1, CXCL2, CCL2, CCL4 and CCL5, CCL11, IL-1β & IL-1α. The analysis
was accomplished following standard protocols at the Proteomics core facility of
Medical University of South Carolina.

Statistical Analysis
Graph Pad Prism4 Software San Diego, CA was used to analyze the
Data; Data were expressed as the means ± S.E from at least three independent
samples. Statistical difference among groups was analyzed using the Mann–
Whitney U-test (in vivo) or Unpaired Student's t-test (in vitro/ex-vivo, RNA
analysis). Two-tailed P values of <0.05 were considered as significant.
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CHAPTER 3
ZnONWs INDUCE STERILE INFLMMATION
IN DIFFERENTMOUSE MODELS
Introduction:
Physicochemical properties, such as size and shape, determine the
interaction between ENMs and immune systems. The morphology of ENMs is
one of the most important aspects for nano-toxicology. A novel class of a ZnO
nanomaterials, called ZnONW, are being produced recently in high tonnage.
They have a unique shape and size that differ from spherical ZnONP, which
have been on the market for decades. The rapid production rate and enormous
quantities substantially increase the risk exposure to ZnONW through different
exposure routes that may vary depending on occupational and environmental
exposure. During the production of ZnONW, workers could be exposed to free
ZnONW in the air.
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On the other hand, public exposure to ZnONW could occur through using
products that contain ZnONW or through the release of ZnONW into the
environment. The general exposure routes to ZnONW are inhalation, skin
contact, and ingestion. The small size and unique shape make their exposure
unavoidable, and a change in the shape could elicit different immune responses
and could impact their uptake and recognition by the immune system. Moreover,
limited data are available related to ZnONW toxicity as well as their acute
inflammatory potential. In addition, long-term consequences of exposure to
ZnONW are unknown.
Therefore, the aim was to assess the adverse effects of ZnONW and their
ability to induce inflammation. Such studies are required to ensure the safe
production and use of ZnONW.
The consequences of local /systemic inflammatory responses to ZnONW
were investigated. First, the local inflammation in the air pouch was evaluated.
The air-pouch provides a localized inflammatory setting that mimics skin
exposure. Also, different cytokines and chemokines responsible for any cellular
infiltration to the site of exposure were examined. Next, the consequences of
systemic inflammatory responses to ZnONW were assessed using a lung
inflammation model. Finally, the cellular mediators involved in the recruitment of
inflammatory cells into the lungs were analyzed.
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Results:
ZnONWs induce inflammation in a murine air-pouch model
One way that exposure to ZnONW can occur is through dermal contact;
however, to the best of our knowledge, the possibility for ZnONW to be
considered inflammatory irritants or to penetrate the skin have not been studied
yet. Thus, whether exposure to ZnONW could lead to any local inflammatory
response was explored. A murine air pouch model was used to assess the
potential localized inflammation caused by ZnONW. The air pouch provides a
localized environment allowing to study infiltration of immune cells in response to
any inflammatory agent or irritant. In this experiment, the air pouch was
established by injecting 5 ml of sterile air subcutaneously into the back of the
mice. After three days, another 3 ml of sterile air was injected into the pouch.
Three days later, 2 mg of ZnONW in 500μl of endotoxin-free PBS was injected
into the air pouch. As controls, PBS alone (negative) or SiONP (2 mg each) were
injected into the air pouch. The mice were euthanized six hours after particle or
PBS administration, and air pouch lavage was collected with 3 ml of PBS (Fig.
6). A flow cytometry analysis and the cytospin of the air-pouch lavage revealed,
as expected from our previous study, that in SiONP-treated mice, there was
induced neutrophilic inflammation but no significant infiltration of macrophages
or eosinophils (Fig.7a&b). In contrast, ZnONW showed a significant increase in
both macrophages and eosinophils. Although a neutrophil influx was observed
from ZnONW, it was relatively weaker compared to SiONP-exposed mice. These
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results suggest that ZnONW-induced inflammation is both qualitatively and
quantitatively different from that induced by SiONP.

Inflammatory mediators induced by ZnONW exposure in an air pouch
Because ZnONW induce inflammation by the recruitment of eosinophils
and macrophages into the air pouch, which cellular mediators contribute to this
distinct pattern of inflammation in the air-pouch was explored. Therefore, a
multiplex analysis for the air pouch lavage from PBS or particle-treated mice was
conducted. The analysis was performed in collaboration with Dr. Twal from the
Medical University of South Carolina to test the levels of various inflammatory
proteins. The following cytokines and chemokines were selected based on the
cells detected in the air pouch: IL-1α, IL-1β, and TNF-α, IL-6, CXCL1, CCL2,
CCL3, CCL4, and GM-CSF for macrophages; CXCL1-specific neutrophilic
chemokine; CCL5 and CCL11 for eosinophils; and CCL2, CCL4, and CCL3
macrophage-specific chemokines. The multiplex analysis showed that in the air
pouch, there was a significant increase in CCL11, CCL2, and CXCL1 (Fig. 8a)
and IL-6 and TNF-α, while for IL-1β, it was only detected with SiONPs (Fig. 8b),
which is consistent with cells types recruited in the air pouch. These findings
indicate that macrophages and eosinophils are the major cell types that
contribute to inflammation induced by ZnONW in the air pouch; however, the
actual events and pathways involved in the inflammation are not yet identified.
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Lung inflammation induced by ZnONWs
Inhalation is one of the most common exposure routes for ZnONW.
Previous studies investigated inflammation induced by ZnONP in lung
inflammation models; however, ZnONW has different physical properties than
ZnONP but similar chemical compositions. Thus, whether ZnONW promote lung
inflammation was examined using an acute two-day lung inflammation model.
The mice were treated with antibiotics for a week before surgery to avoid
infection after surgery, and after one week, the mice were surgically instilled
(intra-tracheal) with endotoxin-free PBS (negative control) or 0.67 mg of
endotoxin-free SiONP (positive control) or 0.67 mg of ZnONWs suspended in
PBS without sonication. Particle suspension was vortexed before instillation to
avoid the settling of the particles. The mice were continuously administered
antibiotics until euthanized two days later. The lungs were lavaged, and
bronchial alveolar lavage fluids (BALFs) were obtained. Both SiONP and
ZnONW led to a massive influx of leukocytes in the lungs. Both the flow
cytometry analysis and the cytospin of BALFs showed that macrophages and
eosinophils were the predominant cells infiltrating the lungs with ZnONW, while
SiONP only recruited neutrophils (Fig 9a). These data indicate that ZnONW
have the ability to induce sterile inflammation that is distinct from the
inflammation induced by other sterile nanoparticles, such as SiONP.
Inflammatory mediators induced by ZnONW exposure in the lungs
Similar to the air pouch model, the mediators that contribute to this
distinct pattern of a sterile inflammatory response in the lungs were assessed. A
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multiplex analysis for BALFs from PBS or particle-treated mice was performed to
measure various inflammatory proteins. The following cytokines and chemokines
were selected based on the cells detected in the lungs: IL-1α, IL-1β, TNF-α, IL-6,
CXCL1,

CCL2,

CCL3,

CCL4,

and

GM-CSF.

For

macrophage-specific

chemokines, CCL2, CCL3, and CCL4 were selected. CXCL1 was selected for
neutrophils, and CCL5 and CCL11 were selected for eosinophils. In the lungs,
the levels of IL-6, TNF-α, CCL2, and CCL11 were elevated in ZnONW-treated
mice; however, significant levels of IL-1β and CXCL1 were detected in BALF,
which is consistent with neutrophilic inflammation that was induced by the
SiONP administrated mice. These findings indicate that macrophages and
eosinophils are the major cell types that contribute to inflammation induced by
ZnONW in the lungs; however, the actual events and pathways involved in
inflammation require further investigation.
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Discussion:
ZnONW has been introduced as part of everyday consumer products. It is
important to protect workers and end users from the inhalation of potentially
innocuous ENMs. To the best knowledge, inadequate data are available in the
literature regarding the biological effects of ZnONW in vivo. To address this gap
in knowledge, in this chapter, the consequences of local and systemic
inflammatory responses to ZnONW investigated using in a mouse model have
been discussed. Such studies are required to ensure the safe production and
use of ZnONW.
Local exposure such as dermal contact is considered a possible common
exposure mode to ZnONW. Previous studies investigated dermal exposure to
sunscreens containing ZnONP in both human and animal experimental models
[227, 228]. ZnONP from sunscreen penetrate only the epidermis outer layer
(stratum corneum) and were found in skin fold areas though not beyond them.
These data suggested that skin exposure hazards of ZnONP are minimal and
limited, and thus it is safe to use ZnONP in sunscreens [229-231]; however,
most of these studies were done using healthy contact skin. Therefore, the skin
exposure hazard of ZnONP for compromised and damaged skin is unknown.
Further studies are necessary to elucidate this issue.
In this study, and for the first time, a murine air pouch model was used to
simulate local exposure to ZnONW. Earlier studies from the laboratory showed
that crystalline silica exposure (CS) induced neutrophilic inflammation in the air
pouch model with a significant increase in the levels of IL-1β and LTB4 [232].
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This type of inflammation observed with CS is linked to lipidosome activation and
LTB4 production as well as to the NLRP3 inflammasome pathway, leading to
caspase-1 activation [232, 233]. In this study, ZnONWs-induced inflammation
resulted in the infiltration of macrophages and eosinophils and the production of
CCL11, CCL2, IL-6, and TNF-α but not IL-β or LTB4. This is in contrast with
significant neutrophilic inflammation induced by SiONPs treatment at the site of
exposure (Fig. 7a, b) and significant levels of IL-β and LTB4 in the air pouch
lavage (data not shown), as expected. Because IL-6 and TNF-α are produced
after ZnONWs exposure, it appears that inflammation induced by ZnONWs is
mediated via the NF-Κβ pathway.
In addition to skin contact, inhalation is a general exposure route to
ZnONW. Previous studies with ZnONP revealed that lung inflammation was
detected in mice and rats exposed to ZnONP [153, 154, 234]. Most ZnONP
animal studies were performed using allergic airway inflammation models that
are prone to eosinophilic inflammation [153, 155, 158, 234]. It has been
suggested that Zn2+ ions dissolved from ZnONP might be involved in ZnONPinduced lung inflammation [92]. Nevertheless, the change in the morphology of
ZnONW may influence the cellular uptake mechanisms and may cause a
different immune response in vivo. Currently, workers are exposed to ZnONW,
among other ENMs, without any permissible exposure limits. Respiratory
diseases, such as fibrosis, asbestosis, and lung cancer, have been linked to
inhalation exposure to fiber materials, such as carbon nanotubes and asbestos
[235-237]. ZnONW has similar geometry properties as carbon nanotubes and
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asbestos fibers. The intratracheal instillation of a 50mg/kg dose of CNTs induces
pulmonary inflammation in mice through the recruitment of neutrophils and the
activation of B cells [238]. Thus, ZnONW may need to be treated with the same
caution as known inflammatory and carcinogenic materials, such as carbon
nanotubes and asbestos. Based on the data from the murine inflammatory
model, ZnONW induce a significant permeation of eosinophils and macrophages
in BALFs, which was observed two days after ZnONW instillation without any
prior sensitization (Fig. 9a, b). Furthermore, CCL11 (Eotaxin) and CCL2
chemokines were identified as cellular mediators that are responsible for
recruiting eosinophils and macrophages into the lungs after ZnONW exposure.
In addition, elevated levels of IL-6 and TNF-α were detected in BALF. Previous
studies with other ENMs, such as TiO2NP and NiONP, reported eosinophilic
inflammation in mice with OVA sensitization or at day 4 post-lung instillation,
respectively [239, 240]. The exposure of rod-like carbon nanotubes (rCNT) also
triggered eosinophilic inflammation in wild-type mice after 4 h/day for four
consecutive days of exposure, while tangled CNT (tCNT) did not elicit any
inflammatory response [241]. The results suggest that the sterile inflammation
induced by ZnONW is distinct from other ENMs-induced inflammation, and the
major difference is related to the recruitment of eosinophils at the site of
exposure by ZnONW compared to neutrophilic inflammation with SiONP.
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3 ml sterile air to
maintain air pouch

5 ml sterile air s.c.
into back of mice

3 days

•

Particles

Air pouch is lavaged with 3
ml PBS
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Flow Cytometry.

•
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the inflammatory cells).

•
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various cytokines and
chemokines
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Figure 6: Air pouch Model Experimental set-up.
Five ml of sterile air was injected into the back of mice subcutaneously to
generate an air pouch. To maintain the air pouch 3 ml of sterile air was injected
into the pouch Three days later. After 3 days, 2 mg of particles in 500 μl of
endotoxin-free PBS was injected into the air pouch. Control animals received
500 μl of endotoxin-free PBS. After 6 hours of injection, mice were euthanized
and the air pouch was lavaged with 3ml of cold PBS.
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Figure 7: Local inflammation induced by ZnONWs in the air pouch.
Sterile air was injected s.c. on the back of the wild-type (WT) mice to form an air
pouch and exposed to nanoparticles (ZnONWs or SiONP) or PBS as described
in methods. Six hours post particle exposure the air pouch was lavaged with 3ml
of buffer to assess infiltrating immune cells. The total number of leukocytes and
differential count for cell types recruited in the air-pouch are indicated (a).
Cytosine slides showing macrophage (red arrow), neutrophils (blue arrow) and
eosinophils (black arrow) (b). Data are expressed as mean ± SE. *p<0.05, ***p<
0.001 non-parametric t-test. Data are representative of at least five mice per
group.
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Figure 8: Inflammatory mediators induced by ZnONWs exposure in lung.
Cytokines and chemokines levels were analyzed in air-pouch lavage from PBS or
particles treated mice using Multiplex analysis. Levels of various inflammatory
proteins CCL2, CCL4, CCL11, CXCL1 and CXCL2 levels (a). IL-6, TNF-α and IL1β levels (b). Data represent at least 5 mice 656 per group; error bars denote
mean ± SEM. *P < 0.03, **P < 0.009, ***P < 0.0007; 657 Unpaired t-test.
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0
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Figure 9: Nano-particle induced acute lung inflammation.
WT mice were intratracheal instilled with nanoparticles (ZnONW or SiONP) or
PBS as described in methods. Lungs were lavaged with 3ml of buffer to assess
infiltrating immune cells as identified by flow cytometry of BALFs (a). Total
number of leukocytes and differential count for cell types recruited in the lung are
indicated above. Representative cytospin slides showing macrophages (red
arrow), neutrophils (blue arrow) and eosinophils (black arrow) (b). Data are
expressed as mean ± SE. *p<0.05, ***p< 0.001 non-parametric t-test. Data are
representative of at least five mice per group.
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Figure 10: Inflammatory mediators induced by ZnONWs exposure in lung.
Cytokines and chemokines levels were analyzed in BALFs from PBS or particles
treated mice using Multiplex analysis. Levels of various inflammatory proteins
CCL2, CCL4, CCL11 and CXCL1 levels (a). IL-6, TNF-α and IL-1β levels (b).
Data represent at least 5 mice 656 per group; error bars denote mean ± SEM. *P
< 0.03, **P < 0.009, ***P < 0.0007; 657 Unpaired t-test.
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CHAPTER 4
CELLULAR AND MOLECULAR MEDIATORS INDUCED BY
ZNONWs EXPOSURE
Introduction:
ZnONP toxicity has been extensity studies in a different mammalian cell
lines [242]. The uptake mechanism and biological effect of ZnONP has also
been studied in several in vivo and in vitro studies; however, novel ZnONW,
which have a one-dimensional shape, were investigated in this study. The
uptake and recognition mechanisms of these nanowires have not yet been
identified. Moreover, most toxicity studies conducted with ZnONP showed that
their toxicity is due to the solubility of ZnONP to zinc ions [52, 92, 93, 243, 244].
Still, the change in the physical properties of ZnONW may actually alter their
interactions with immune cells. Subsequently, this could impact the uptake
pathways of ZnONW, leading to differences in biological responses to ZnONW.
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Very limited data are available related to ZnONW toxicity and
translocation within the cells. ZnO nano-rods were found to be more toxic than
ZnONP in Hela cells [243]. Exposure to rod-shaped ZnONP (100-200 nm)
induces toxicity in human aortic endothelial cells at 10 and 50 μg/mL
concentrations [244]. Furthermore, ZnONW were found to be toxic to HMMs at a
concentration of 20μg/ml after 24 hours of exposure [92]. Pathogen uptake and
degradation occur through the phagosomal maturation pathway such as
endocytic pathway, and particles undergo the same process. It is a wellorganized process that allows for particle transition into the intracellular
compartments of the cell. First, it begins with early endocytic vesicles that
contain the particles in the peripheral cytoplasm. Then, the particles within the
early endocytic content are delivered to early endosomes (EE) that have a 6.2
pH level. EEs receive cargo from differed pathways, such as the clathrin and
caveolar mediated pathways or the EEC and ARF6-dependent pathways. The
content of EE is carried to large vesicles called late endosomes (LE), where the
pH level is gradually reduced to 5.5. Next, in the perinuclear region, the plasma
membrane and other compartments are recycled and sent back to the cell
surface through recycling endosomes. Lastly, LEs fuse to the lysosomes with a
final pH level equal to 4.5, and the contents are digested by the lysosomal
hydrolases [245].
Under acidic conditions, such as the lysosomal vacuoles of the cells,
ZnO has a highly sensitive dissolution point. The release of the zinc cation from
ZnONP induces phagosomal membrane destabilization, leading to autophagy
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and cell death [246]. Furthermore, the production of lysosomal proteases
promotes ROS generation and induces the activation of inflammatory pathways.
According to Roy et al., ZnONP triggers the production of ROS and enhance
inflammatory signaling pathways, such as the MAPK kinases and NF-κB
cascades, as well as the production of pro-inflammatory cytokines, such as IL-8,
IL-6, and TNF-α [141]. Furthermore, they found that caveolae-mediated
endocytosis is the primary mechanism in which ZnONP is taken up by peritoneal
macrophage.
In chapter three, it has been demonstrated that ZnONW induced sterile
inflammation by recruiting macrophages and eosinophils both in lung and airpouch mouse models. In addition, ZnONW induced macrophage-specific (CCL2)
and eosinophil-specific (CCL11) chemokines and cytokines, such as IL-6 and
TNF-α, in the air pouch and lungs because tissue-resident macrophages and
epithelial cells coordinate the inflammatory response. Thus, it is imperative to
determine which cell types produce these chemokines and cytokines in
response to ZnONW. The identification and understanding of the cellular
mediators that are involved in inflammation induced by ZnONW would help in
defining the underlying inflammatory mechanisms activated by ZnONW. This
understanding might also provide useful insights into and knowledge of the
inflammatory potential of other ENMs with similar shapes and sizes as ZnONW.
In

this

study,

the

cellular

uptake,

subcellular

localization,

and

inflammatory and toxic effects of ZnONW on cellular models were investigated.
To represent phagocytic cells, BMDMs and RAW 264.7 cells were chosen, while
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LKR13 cells were chosen to represent bronchial epithelial cells. First, to track
ZnONW’ cellular uptake and localization, it was necessary to generate
fluorescent-labeled ZnONW (FITC-ZnONW). BMDM was exposed to FITCZnONW, and the uptake and localization of these particles in the lysosomes was
detected using confocal microscopy. To prevent the solubilization of ZnONW,
Bafilomycin-A1 (Baf-A1), a macrolide antibiotic isolated from the streptomyces
species that inhibits the vacuolar H+ATPase (V-ATPase), was used to inhibit the
acidification of phagosomes. Next, the cell types that are involved in the
production of IL-6 and TNF-α cytokines and chemokines CCL11 and CCL2,
which were integrated into the inflammatory response in vivo in mouse models,
were identified. BMDM, RWA264.7, and LKR13 cell supernatants were used to
measure the levels of TNF-α, IL-6, IL-1β, and LTB4 and CCL11 and CCL2.
Then, the requirement of phagocytosis for IL-6 and TNF-α production was
investigated using CytD. Cell lysate was used to measure the fold changes in
the expression levels of mRNA of TNF-α, IL-6, CCL2, CCL3, CCL4, CXCL1, and
CCL11 in BMDMs, RAW 264.7 cells, and LKR13 cells.

64

Results:
Preparation and characterization
ZnONWs were synthesized using downstream microwave plasma reactor
methods with a rapid oxidation of zinc powders in a gas phase [23]. The
dimensions of ZnONWs as determined by Scanning Electron Microscopy (SEM)
were around 20-120 nm in diameter and 5000 nm in length (Figure 11).

Cytotoxicity of ZnONWs for BMDM, LKR13, and RAW 264.7 cells
Previous studies showed the toxicity of ZnONP for mammalian cells in
vitro [13, 25-27]. ZnONP induced toxicity in a variety of cells, such as kidney,
liver, and lung cell lines [12, 13, and 26]. To investigate whether ZnONW exhibit
distinct cytotoxicity profiles, both dose response and time course studies were
conducted. The MTT assay was used to measure the metabolic activity of cells.
First, macrophage cell lines (RAW-264.7 cells) were stimulated with different
doses of ZnONW of 5, 10, 20, and 100 μg/ml for six hours. It was observed that
at 5, 10, and 20 μg/ml, and the cells were 95% viable, whereas 100 μg/ml
reduced the cells’ viability by approximately 20% (Fig. 12a). As a result, 20 μg/ml
and 100 μg/ml doses were selected to perform the time course studies. As
shown (Fig. 12b), nearly 100% of the cells were viable after 18 hours of
treatment with 20 μg/ml dose of ZnONW, whereas more than a 50% cell death
was observed at 100 μg/ml. The cytotoxicity of ZnONW was also determined in
other cell types, such as BMDM and LKR13 cells. In LKR13, a similar toxicity
trend as RAW-264.7 cells was observed, as shown in Fig. 13a. In BMDM, a 20
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μg/ml concentration of ZnONW induced significant toxicity after 18 hours of
exposure by a reduction in cell viability up to 30%, whereas 100 μg/ml induced
toxicity after only 4 hours of ZnONWs stimulation (Fig. 13b). Thus, all further
studies with different cell types were performed with 20 μg/ml or less doses of
ZnONW for 6 hours of treatment.

Cellular uptake and translocation of ZnONWs
To investigate the cellular uptake of ZnONW in BMDMs cells, FITClabeled ZnONW was generated as previously described [20]. Since ZnONW
tend to dissolve in the acidic condition, we used Baf-A1 to block the acidification
and to facilitate the visualization of ZnONWs in the cells. In order to investigate
the effect of Baf-A1 on blocking the acidification of the phagolysosome Acridine
orange staining was used. Cells were primed with LPS for three hours followed
by a one-hour pre-treatment with or without Baf-A1. Then, cells were exposed to
25 µg/ml FITC-labeled ZnONW for three hours and washed. Followed by
Acridine orange staining and examined by confocal microscopy. As shown in Fig
14 ZnONWs treated cells showed enlarged lysosomal compartments whereas in
Baf-A1 treated ZnONWs exposed cells no lysosomal staining was observed.
These data suggested that Baf-A1 prevent block the acidification of the
phagolysosome. To evaluate the uptake of the ZnONWs, cells were primed with
LPS for three hours followed by a one-hour pre-treatment with Baf-A1. Then,
cells were exposed to 25 µg/ml FITC-labeled ZnONW for three hours and
washed and examined by confocal microscopy. As shown in Fig 15, intracellular
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ZnONW was detected only in cells pre-treated with Baf-A1, whereas cells that
were not treated with Baf-A1 did not show an intracellular accumulation of
ZnONW particle. These results suggest that the inhibition of phagolysosome
formation prevents the dissolution of intracellular ZnONWs in the cells.
Next, to track the trans-location of FITC-ZnONW in the cells, LAMP-1
staining, LAMP-1 stains late endosomal and lysosomal compartments in the cell,
was used. Baf-A1-treated BMDMs were stimulated with FITC-ZnONW followed
by LAMP-1 staining. The ZnONW treatments exhibited lysosomal clumping
(Fig.16a). The LAMP-1 staining was overlapped by the FITC- ZnONW (Fig.16b).

ZnONW induces the release of pro-inflammatory mediators by
macrophages in vitro
To examine the inflammatory potential of ZnONW, BMDMs were treated
with ZnONW, and the levels of pro-inflammatory cytokines, such as IL-1β, IL-6,
and TNF-α, as well as the lipid chemokine LTB4 were measured in culture
supernatants. Our previous study showed that SiONP induce the production of
IL-1β and LTB4. Thus SiONP was used as positive controls for the production of
IL-1β and LTB4 [19, 28]. The treatment of BMDMs with ZnONW or ZnONP did
not result in any significant accumulation of IL-1β or LTB4 (Fig. 17a). As
expected, SiONP treatments induced the production of IL-1β and LTB4 in
BMDMs (Fig. 17a). ZnONW induced a dose-dependent increase in the
production of the cytokines IL-6 and TNF-α (Fig. 17b). Furthermore, treatment
with Baf-A1 significantly reduced the ZnONW-induced production of these
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cytokines (Fig. 17b). A similar dose-dependent cytokine induction profile was
observed in RAW 264.7 cells treated with ZnONW (Fig 18); however, the
exposure of lung epithelial cell line LKR13 to ZnONW did not result in either IL-6
or TNF-α production. These results suggest that ZnONW could induce the
synthesis of pro-inflammatory cytokines IL-6 and TNF-α but not IL-1β or LTB4.
The soluble Zn ions are mediating the toxicity of ZnONWs. However, did Zn ions
induce the production of these cytokines? In order to investigate the ability of
soluble zinc induce the induction of IL-6 and TNF-α. BMDMs were treated with
ZnCl₂ for six hours. Then IL-6 and TNF-α were measured in culture supernatants
supernatant. Interestingly, treatment of cells with ZnCl₂ did not induce the
production of these cytokines (Fig 19).

ZnONWs upregulate TNF-α, IL-6, CCL11, and CCL2 at mRNA expression
level
Previous studies showed that CS exposure in the lungs leads to an
increase in LTB4, IL-1β, and many CXC chemokines [232]. Because ZnONWinduced inflammation is significantly different from that of CS-induced
inflammation, the mediators that contribute to this distinct pattern of inflammatory
responses were examined. The mRNA levels of various cytokines and
chemokines that regulate macrophage and eosinophilic inflammation were
measured based on the cell types detected in in vivo studies. In BMDMs (Fig 20)
and RAW 246.7 cells (Fig 21), the ZnONW and ZnONP resulted in significantly
increased CCL4 and CCL11 and IL-6 and TNF-α expression. In addition, in the
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culture supernatant, the CCL11 level was significantly increased, whereas CCL2
was not significant (Fig 20). In contrast, the exposure of the lung epithelial cell
line LKR-13 led to an enhanced expression of CCL2 and CCL11 mRNAs and
protein levels in cell supernatants by ZnONW and ZnONP (Fig 22). The CCL11
protein was upregulated in culture supernatants of ZnONWs exposed BMDMs
and LKR13 cells (Fig 23). Whereas CCL2 were levels increased only in
supernatants from LKR13 cells but not in BMDMs (Fig 23).These findings
suggest a basis for the recruitment of macrophages and eosinophils due to the
exposure of ZnONW.

Phagocytosis is required for ZnONWs-induced TNF-α and IL-6 production
To assess the cellular uptake mechanisms of ZnONW, cells were pretreated with cytochalasin D (CytD) (phagocytosis inhibitor) and Baf-A1 [19, 24].
CytD treated cells did not show intracellular FITC-ZnONW, suggesting that
phagocytosis is required for their uptake (Fig 24a).Furthermore, treatment with
CytD significantly reduced the ZnONWs induced production of IL-6 and TNF-α
(Fig 24b).
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Discussion:
ZnONP has been known to induce toxicity and cell death to different
mammalian cell lines [12, 32, 40-42]. It has been suggested that the solubility of
ZnO in the acidic vacuoles is the underlying cause of ZnONP toxicity; however,
the physical properties play a major role in ENPs toxicity. Thus, whether the
change in the shape of high aspect ZnONW elicits a different toxicity behavior
than ZnONP was investigated. It was found that ZnONW induced toxicity in
different cell types, including BMDM, RAW 267.4, and LKR13 cells (Fig. 12, 13).
Significant cell death was observed at 20 μg/ml of ZnONW after 18 hours of
exposure; however, at 100 μg/ml, the cell viability was further reduced even at
four hours of ZnONW exposure (Fig. 12). These results are in agreement with
other previous studies, which suggested that ZnONW induce toxicity in cultured
cells [4, 43]. Thus, all further studies with different cell types were performed at
20 μg/ml or less doses of ZnONW for six hours of exposure.
Macrophages play an important role in innate immune responses against
ENMs [32]. The uptake mechanisms of the ENMs largely depend on the
physiochemical properties of the particles, such as shape and size. Previous
studies showed that the cellular uptake of ENMs, such as ZnONP, gold
nanoparticles, sliver nanoparticles, iron oxide nanoparticles, and carbon
nanotubes, is facilitated via clathrin, caveolae, and/or scavenger receptormediated endocytic pathways [141, 247-252]. In addition, very little free Zn ions
exist in the cytosol of healthy cells, and they are mostly found to be bounded to
proteins, such as metallothionins, or to be sequestered in cellular organelles,
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such as mitochondria and lysosomes [253]. According to Xia et al., only small
faint particles remnants were detected in RAW 264.7 after exposure to FITClabeled ZnONP [224]. This could be explained by the dissolution of ZnONP
inside the acidic vacuoles of the cells. Therefore, Baf-A1 was used to block the
acidification of the acidic compartment of the cells (lysosome). To assess the
effect of Baf-A1 on lysosomal acidification, acridine orange staining was used.
Acridine orange emits green fluorescence in nuclear and cytoplasmic
compartments, while acidic lysosomes or phagolysosome are stained orange to
red. ZnONW-treated cells showed red enlarged lysosomal compartments.
Acridine orange staining in the lysosomal compartments was completely absent
in Baf-A1-treated cells exposed to ZnONW (Fig. 14). This indicated that Baf-A1
inhibited the acidification of the acidic compartment in the cells.
ZnONW was detected in intracellular compartments only in the presence
of Baf-A1 (Fig. 15 a and b), an inhibitor of vacuolar acidification. It was concluded
that in the absence of Baf-A1, the ZnONW taken up by these cells are readily
solubilized to generate Zn ions.
The inflammatory pathways triggered by ENMs, such as SiONP, titanium
dioxide nanoparticles (TiONP), and carbon nanotubes (CNT), were all linked to
the activation of the inflammasome –caspase-1 related pathway (NLRP3) and
the release of the cytokine IL-1 β [95, 96]. The current studies showed that the
stimulation of BMDMs and RAW 267.4 cells with ZnONW did not induce IL- β or
LTB4 production, whereas SiONP induced both IL- β and LTB4 (Fig. 17a), as
expected. These results suggest that ZnONW do not activate the NLRP3
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inflammasome pathway; however, ZnONP is known to induce the production of
IL-6 and TNF-α [138, 254, 255]. The results also showed that ZnONW exposure
leads to a significant increase in the production of both IL-6 and TNF-α in a dosedependent manner in RAW267.4 (Fig. 18) and BMDM but not in LKR13 (Fig.17b)
cells; however, in the presence of Baf-A1, exposure to ZnONW did not result in
any IL-6 or TNF-α production, suggesting that soluble Zn ions mediate the
induction of these cytokines (Fig.17b). Interestingly, the treatment of cells with
ZnCl2 did not induce the production of these cytokines (data not shown). Thus,
the uptake of the particles as well as their dissolution within the phagolysosomeal
compartment appears essential for the induction of cytokines, and the externally
provided ZnCl2 is not sufficient for activating the production of pro-inflammatory
cytokines. Furthermore, both ZnONP [138, 254, 255] and ZnONW (current study)
induced a similar cytokine profile, which suggests that it is the chemical nature
rather than the shape of the ZnO ENMs that is the primary cause of the observed
cytokine profile. Together, these results suggest that ZnONW induce a distinct
inflammatory pathway from SiONP and other ENMs.
The molecular basis for the in vivo ZnONW-mediated cellular infiltration
was further analyzed in vitro in different cell types. The CCL11, CCL2, IL-6, and
TNF-α expression levels in BMDM (Fig. 19), RAW 267.4 (Fig. 20), and LKR13
cells (Fig. 21) stimulated with ZnONW was examined. The data suggested that
lung epithelial cells and resident macrophages could be the primary responders
to ZnONW, producing CCL2 and CCL11 and leading to macrophage and
eosinophil recruitment to the site of exposure. Moreover, macrophages are
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considered one of the major sources for TNF-α production upon activation. When
cells are exposed to TNF-α, NF-kβ is activated, leading to the expression of
many pro-inflammatory cytokines genes, such as IL-6 [256]. Furthermore, the
upregulation of CCL11 and CCL2 mRNA expression is mediated via the
intracellular signaling of TNF-α through the NF-Κβ pathway [257]. Because NFΚβ is a transcription factor known to regulate both CCL11 and CCL2 promoters
and to signal downstream of both the IL-6 and TNF receptors [257-259], further
studies are needed to define the NF-Κβ signaling pathways that are activated
upon ZnONW exposure and therefore involved in the production of CCL11,
CLL2, IL-6, and TNF-α.
Phagocytosis typically involves the uptake of larger particles (>250nm).
Aggregates of the FITC-ZnONW in the vacuoles (Fig. 15a) were consistently
observed, suggesting that they may be taken up by the actin-dependent
endocytic pathways. Consistent with this notion, treatment with CytD completely
blocked the uptake of FITC-ZnONW (Fig. 23a). Moreover, CytD exposure to
ZnONW did not result in any IL-6 or TNF-α production (Fig. 23b), suggesting that
phagocytosis is required for the uptake and the production of IL-6 and TNF-α.
In summary, ZnONW induced the production of pro-inflammatory
cytokines IL-6 and TNF-α and and eosinophil-specific CCL11 in BMDMs. In
contrast LKE13 cells induce the production of CCL2 and CCL11 only but not IL-6
and TNF-α. These results suggest that lung epithelial cells could be the primary
source for CLL2 and CLL11 which lead to recruitment of macrophage and
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eosinophils to the site of exposure. And macrophages as the secondary
responder that in turn produce the IL-6, TNF-α and CCL11.
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Figure 11: Scanning Electron Microscopy (SEM) of ZnONWs.
Scanning Electron Microscopy (SEM) image of ZnONWs indicating size of
individual nanowires. The dimensions of ZnONWs as determined by Scanning
Electron Microscopy (SEM) were around 20-120 nm in diameter with 5000 nm in
length.
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Figure 12: Cytotoxicity assessment of ZnONW.
0.5x106 cells /ml of RAW-264.7 cells were stimulated with different
concentrations for different times with ZnONW as indicated or with PBS as
negative control. Cell viability was assessed using MTT test. RAW-264.7 cells
were stimulated with ZnONW 5, 10, 20 and 100 μg/ml for 6 hours (a). Time
course study for RAW-264.7 cells, cells were stimulated with ZnONW 20μg/ml &
100μg/ml concentrations for 2, 4, 6 & 18 hours (b). Data represented is from
one of the three experiments. Data are expressed as mean ± SE. **p< 0.01,
***p< 0.001 non-parametric-test.
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Figure 13: Cytotoxicity assessment of ZnONW.
0.5x106 cells /ml of BMDMs from WT mice, LKR13 cells were stimulated with
different concentrations for different times points with ZnONW as indicated or
with PBS as negative control. Cell viability was assessed using MTT test. LKR13
cells were stimulated with ZnONW 20μg/ml & 100μg/ml concentrations for 2, 4, 6
& 18 hours (a). BMDMs were stimulated with ZnONW 20μg/ml & 100μg/ml
concentrations for 2, 4, 6 & 18 hours (b). Data represented is from one of the
three experiments. Data are expressed as mean ± SE. **p< 0.01, ***p< 0.001
non-parametric-test.
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Figure 14: Inhibition of phagolysosome formation using Baf-A1 inhibitor.
LPS-primed BMDMs were stimulated with 25 μg/ml ZnONW for 3 h in the
presence (b) or absence of Baf-A1 (a). Cells were stained with acridine orange
for 30 min after ZnONWs exposure. Acridine orange stains the acidic vacuoles in
the cells such as phagolysosome with orange to red color whereas DNA/RNA or
cytoplasm of the cell with green color. Cells were visualized by Nikon A1 confocal
microscopy. A minimum of five fields were captured for each sample in every
experiment.
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Figure 15: Cellular uptake of ZnONWs.
LPS-primed BMDM cells were stimulated with 30µg/ml FITC-ZnONW for 3h in
the presence or absence of Baf-A1 (1μg/ml). Cells were stained with choleratoxin B (red) and DAPI (blue) for 20min after fixation and visualized by Nikon A1
confocal microscopy (a). The density of intracellular ZnONW particles was
calculated as number of particle events/ high power field as indicated in (b). Data
represented is from one of the three experiments. Data are expressed as mean
± SE. **p< 0.01, ***p< 0.001 non-parametric-test.
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Figure 16: Sub-cellular localization of ZnONWs.
LPS-primed BMDM cells were stimulated with 30 µg/ml FITC-ZnONW for 3h in
the presence or absence of Baf-A1 (1 μg/ml). After fixation and permeabilization,
cells were stained with 1 μg/ml 1 μg/ml anti LAMP-1 antibody followed by Alexa
594 labeled antibody to visualize lysosomes (red) and DAPI (blue) (a). The
intensity plot shows the overlapping of green and red signals (b).
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Figure 17: ZnONWs exposure induced the release of pro-inflammatory
mediators by macrophages in vitro.
Pro-inflammatory cytokines levels from PBS or particles (ZnONP, ZnONW &
SiONP) exposure in culture supernatants were analyzed using ELISA. IL-1β and
LTB4 levels were measured in BMDMs exposed for 6hrs. Cells were primed with
LPS (10ng/ml) for 3h and washed and then treated with ZnONW, ZnONP, SiONP
or PBS (a). BMDMs cells were primed with LPS (10ng/ml) for 3h and washed
then treated with or without Baf-A1. Then cells were treated with ZnONW or PBS
for 6hrs, IL-6 and TNF-α levels were measured as indicated (b).

Data

represented is from one of the three experiments. Data are expressed as mean ±
SE. **p< 0.01, ***p< 0.001 non-parametric-test.

81

Figure 18: ZnONWs exposure induced the release of pro-inflammatory
mediators by macrophages in vitro.
Pro-inflammatory cytokine levels from PBS or particles (ZnONP, ZnONW &
SiONP) treated RAW264.7 cell culture supernatants were analyzed using
ELISA. RAW 264.7 cells were stimulated with LPS (10 ng/ml) for 3h. Then cells
were treated with ZnONW, ZnONP, SiONP or PBS for 6hrs (a) or 18 hrs (b) and
the IL-6 and TNF-α levels were measured in the supernatants. Data represented
is from one of the three experiments. Data are expressed as mean ± SE. **p<
0.01, ***p< 0.001 non-parametric-test.
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Figure 19: ZnCl2 did not induced the release of IL-6 or TNF-α by
macrophages in vitro.
BMDM cells were stimulated with LPS (10ng/ml) for 3h. Then cells were treated
with ZnONW, ZnONP, ZnCL, SiONP or PBS for 6hrs, IL-6 (a) and TNF-α (b)
levels were measured as indicated in the culture supernatants using ELISA.
Data represented is from one of the three experiments. Data are expressed as
mean ± SE. **p< 0.01, ***p< 0.001 non-parametric-test.
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Figure 20: Inflammatory mediators induced by ZnONWs exposure.
Cytokines and chemokines expression levels were analyzed in BMDM cells and
LKR13 cells from PBS or particles treated cells using qRT-PCR. Various level of
inflammatory genes mainly IL-6, TNF-α, CCL2, CCL4, CCL11, CXCL1 & CXCL2.
(a) Cytokines and chemokines levels from BMDMs cells. (b) from LKR13 cells.
Data represented is from one of the three experiments. Data are expressed as
mean ± SE. **p< 0.01, ***p< 0.001 non-parametric-test.
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Figure 21: Expression levels of inflammatory marker induced by ZnONWs
in RAW 264.7 cells.
Expression of cytokines and chemokines mRNA levels were analyzed in RAW
264.7 cells exposed to PBS or particles treated cells using qRT-PCR.
Inflammatory marker IL-6, TNF-α, CCL2, CCL4, CCL11, CXCL1 and CXCL2.
Data represented is from one of the three experiments. Data are expressed as
mean ± SE. **p< 0.01, ***p< 0.001 non-parametric-test.
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Figure 22: Inflammatory mediators induced by ZnONWs exposure.
Cytokines and chemokines levels were analyzed in LKR13 cells from PBS or
particles treated cells using qRT-PCR. Various level of inflammatory genes
mainly IL-6, TNF-α, CCL2, CCL4, CCL11, CXCL1 & CXCL2. Data represented is
from one of the three experiments. Data are expressed as mean ± SE. **p< 0.01,
***p< 0.001 non-parametric-test.
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Figure 23: CCL11 and CCL2 levels induced by ZnONWs in BMDMs and
LKR13 cells.
The levels of CCL11 and CCL2 proteins were determined in the culture
supernatants from (a) BMDM and (b) LKR13 cells using ELISA. Data
represented is from one of the three experiments. Data are expressed as mean ±
SE. **p< 0.01, ***p< 0.001 non-parametric-test.
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Figure 24: Phagocytosis is required for ZnONWs induced TNF-α and IL-6
production.
10 ng/ml LPS-primed BMDM cells were stimulated with 25 µg/ml FITC-ZnONW
for 2h in the presence or absence of CytD (10µg/ml). Cells were stained with
cholera-toxin B (red) and DAPI (blue) for 20 min after fixation and visualized by
Nikon A1 confocal microscopy (a). BMDMs cells were primed with LPS
(10ng/ml) for 3h and washed then treated with or without (1 μM) Baf-A1. Then
cells were treated with ZnONW or PBS for 6hrs, IL-6 and TNF-α levels were
measured as indicated (b). Data represented is from one of the three
experiments. Data are expressed as mean ± SE. **p< 0.01, ***p< 0.001 nonparametric-test.
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CHAPTER 5
CONCLUSIONS

In the last two decades, with the advent of nanotechnology, the use of
ENMs have become widespread due to their applicability in many areas
including industry, agriculture, and medicine. ENMs are materials that were
created and designed with specific shapes and sizes to produce new materials
at nano-scale. The rapid development and the increase in use of ENMs in
consumer products have created a gap and challenge through limited knowledge
about the safe and sustainable use of ENMs. Previous studies indicated that
some ENMs can be cytotoxic. Furthermore, some forms of ENMs can cross the
blood-brain

barrier

inducing

neurotoxicity,

brain

tissue

damage,

and

inflammation [260]. However, the long-term consequences of exposure to most
of these particles are unknown.
Zinc oxide (ZnO) has long been employed in many consumer products
especially in sunscreen [225]. Despite the common use of ZnONP, the safety of
these particles needs further investigation and the potential biological effects to
humans are still unclear.
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Moreover, the tremendous advancement in the field of nanotechnology
has led to the emergence of new forms of ZnO ENMs called high aspect ratio
ZnONW. These particles are being developed and introduced to the market with
production rate estimated by millions of tons per year. The use of ZnONP is
considered relatively safe, however with ZnONW, there is uncertainty about the
safety of these ZnONW and their impact at the biological level. The rapid
production of ZnONW pose a large of risk exposure for public and foundry
workers.
Here in this study we found that ZnONW induces toxicity and cell death to
BMDM, RAW267.4, and LKR13 cells. Significant toxicity was observed at 20
μg/ml of ZnONWs exposure for 18 hrs. However, at 100 μg/ml the cell viability is
further reduced even at 4h of ZnONWs exposure. Based on previous studies
done with ZnONP as mentioned in chapter 1, the toxicity is mainly due to the
solubility of ZnONP inside the acidic vacuoles of the cells. We speculated that
ZnONW induce toxicity similar to ZnONP since both ZnONW and ZnONP have
the same chemical composition.
The uptake mechanisms of the ENMs largely depend on shape, size and
physiochemical properties of the particles. Previous studies showed that cellular
uptake of ENMs such as ZnONPs, gold nanoparticles, sliver nanoparticles, Iron
oxide nanoparticles and carbon nanotubes is facilitated through different uptake
mechanism based on the size of ENMs [67, 248-250, 260, 261]. ENMs that have
size less than 10 nm cross cell membrane via direct diffusion or non-specific
pathways. Clathrin, caveolae and/or scavenger receptor-mediated endocytic
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pathways were found mainly with ENMs that have a size between 50- 150 nm.
Larger ENMs (200-2000 nm) were believed to be internalize thorough
phagocytosis pathway. Our studies showed that visible uptake of FITC-ZnONW
aggregate with cells that were treated with Baf-A1. Based on the aggregate size
we speculated that these FITC-ZnONW aggregate may be taken up by the actindependent endocytic pathways. Consistent with this notion, treatment with CytD
completely blocked the uptake of FITC-ZnONW. These results indicated that
phagocytosis appeared to be essential for uptake of ZnONW.
Direct contact through skin and airway exposure are the most common
routes of exposure to ZnONW. This current study provided the first experimental
evidence that ZnONW induce localized inflammation in a murine air-pouch
model,

resulting

in

a

broad

inflammatory response

by infiltration

of

macrophages, eosinophils, and neutrophils: production of CCL11, CCL2, IL-6
and TNF-α. In contrast, intra-tracheal instillation of ZnONW in a healthy mouse
without prior sensitization induced eosinophilic air-way inflammation and a tight
and regulated inflammation in the lung by a massive influx in macrophages and
eosinophils as well as remarkable increase in levels of CCL11, CCL2, IL-6 and
TNF-α that are consistent with cell types infiltrated in the lung. The inflammatory
response from ZnONW was distinct and different from SiONPs that induce
neutrophilic inflammation both in lung and air-pouch.
To have a better understanding of this type of inflammation, the
inflammatory mediators induced upon ZnONW exposure were investigated.
Inflammasome (NLRP3) and IL-1β release are considered as common pathway

92

in which ENMs induce sterile inflammation [100]. Previous studies from table 2
above showed that some ENMs such as SiONP, CNT and TiONP induce the
production IL-1β throw the activation of Inflammasome (NLRP3) pathway. On
the other hand most of these studies did not investigated the possibility of
endotoxin (LPS) contamination of ENMs, LPS contamination could lead to a
misleading result since LPS could induce the activation of Inflammasome
(NLRP3) pathway and production of IL-1β. Here, ZnONW was made endotoxinfree by baking at 200°C overnight to overcome the possibility of endotoxin (LPS)
contamination. Earlier studies from our laboratory showed that crystalline silica
exposure (CS) induced neutrophilic inflammation in the air pouch model with a
significant increase in the levels of IL-1β and LTB4 [232]. This type of
inflammation observed with the CS is linked to the lipidosome activation and
LTB4 production as well as NLRP3 inflammasome pathway leading to caspase1 activation [232]. ZnONW did not induce the production of IL-1β nor LTB4.
Indication that ZnONW do not activate the inflammasome pathway. Instead
ZnONW induce the production of IL-6 and TNF-α in a dose-dependent manner.
Since IL-6 and TNF-α are produced after ZnONWs exposure, it appears that
inflammation induced by ZnONWs is mediated via NF-Κβ pathway. IL-6 and
TNF-α level were significantly reduced and after Baf-A1 and CytD treatment,
suggesting that both the uptake and solubility of ZnONW essential for IL-6 and
TNF-α. Moreover, exposure of BMDM to ZnONW induced the production of
CCL11 while LKR13 cells induced both CCL11 and CCL2. The production of
these chemokines and cytokines were consistent with our previous findings to
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the cell types recruited in the site of exposure in lung and air-pouch mouse
model.
ZnONP toxicity was linked to the solubility of the particles under acidic
conditions in the cell. However, pre-treatment of BMDMs with Baf-A1 did not
result of IL-6 or TNF-α production upon ZnONW exposure. These results
indicated that soluble zinc ions were mediating the production of these
cytokines. In addition, treatment of BMDMs with ZnCl2 was not sufficient for the
production of pro-inflammatory cytokines, suggesting that the uptake of ZnONW
and their dissolution within the phagolysosome compartment is required for the
activation and production of IL-6 and TNF-α.
Studying the potential negative health implications for ZnONW exposure
in animal models might give an insight to the possible adverse outcome for
exposure to these particles and other ENMs that have similar properties.
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Figure 25: Graphical summary.
Cells take up ZnONW by phagocytosis process. During phagosome
maturation pH drops and ZnONWs starts to dissolve. The intracellular
dissolution leads to an increase of the Zn ion concentration and lysosomal
destabilization, leading to toxicity and production of IL-6 and TNF-α, CCL2,
and CCL11. Blocking the acidification of phagolysosome with Baf-A1 prevents
the production of these cytokines.
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FUTURE DIRECTIONS

This dissertation studied the potential toxicity and inflammatory effects of
ZnONW in a murine mouse model and cultured cells. Although this study
outlines only the biological consequences for exposure to ZnONW in vivo and
ex-vivo, it raises important issues and questions that are needs to be addressed
and worth investigation.
Studies presented here indicated that ZnONW induce toxicity and cell
death to different cell lines. Toxicity of ENMs depends on both the physical and
chemical properties. Moreover, very little is known and understood about the
mechanisms of ENM toxicity in mammalian cells lines. The fact that ZnONW
have sensitive dissolution points in the acidic aqueous conditions in the cells,
and ZnO dissolution has been shown to play a role in the acute or chronic
toxicity, the novel 1D morphology of ZnONW could lead to a different
toxicological profile. Therefore, future studies could be aimed at understanding
the impacts of the physical properties of ZnONW on toxicity.
Confocal microscopy images revealed that ZnONW inside the cells were
taken up as aggregated in presence of Baf-A1 and not as a single individual
particle. However, we do not know whether this aggression can be reversed or
how long these can be persisting or how they could activate an inflammatory
cascade. Thus, mechanistic studies need to be conducted to investigate
ZnONW’ immunomodulatory effects.
In our previous study, crystalline silica (CS) induced sterile inflammation
through the activation of NLRP3- inflammasome pathway and the production of
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IL-1β and LTB4. Based on our results here, ZnONW induced sterile inflammatory
responses in lung and air-pouch mouse models that were qualitatively and
quantitatively distinct from CS and SiONP. ZnONW induced the recruitments of
eosinophils and macrophages as well as the production of CCL2, CCL11 and IL6, and TNF-α. Previous studies with ZnONP revealed that pulmonary exposure
to ZnONP induce the recruitment of neutrophils in lung. However, here in this
study, ZnONW did not induce the infiltration of neutrophil in the lung; this could
be explained by either the overwhelming cellular infiltration or that ZnONW’
shape elicit a different response than ZnONP.
The cellular basis of the production of these chemokine and cytokines
was investigated. We demonstrated the importance of LKR13 cells in the
production of CCL11 and CCL2, with BMDMs and RAW 264.7 cells as the main
source for IL-6 and TNF-α and its contribution to the production of CCL11.
However, the actual sequence of the production of these chemokines and
cytokines

remains

unknown.

Future

experiments

could

be

aimed

at

understanding how this inflammatory pathway initiates and the molecular
pathways involved need to be examined using inhibitors of phagocytosis and
assessed using Western Blotting techniques.
Lastly, this study could reveal important information about sterile
inflammatory effects of ZnONW which could apply to similar ENMs that may
have similar physical or chemical characteristics to ZnONW.
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ABBREVIATIONS
NM: Nanometer
ENMs: Engineered nanomaterials
ENPs: Engineered nanoparticles
TiO2NP: Titanium dioxide nanoparticle
CeO2NP: Cerium dioxide nanoparticle
Al2O3NP: Aluminum oxide nanoparticle
SiONP: Silicon dioxide nanoparticle
ZnONP: Zinc oxide nanoparticle
CNT: Carbon nanotubes
CS: Crystalline silica
ROS: Reactive oxygen species
DNA: Deoxyribonucleic acid
TWA: Time weighted average
STEL: short-term exposure limit
RNS: Reactive nitrogen species
DAMP: Damage-associated molecular patterns
HMGB-1: High mobility group box 1 protein
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IL-1𝛽: Interleukin-1beta
TNF-α: Tumor necrosis factor alpha
Nrf2: Nuclear factor (erythroid-derived 2)-like 2
MAPK: Mitogen activated protein kinase
NF-𝜅B: Nuclear factor kappa-light-chain enhancer of activated B cells
iNOS: Inducible nitric oxide synthase
ERKs: Extracellular signal-related kinases
LDH: Lactate dehydrogenase
HOCl: Hypochlorous acid
ONOO−: Peroxynitrite
AM: Alveolar macrophages
HARN: High aspect ratio nanomaterials
PARP: Poly-ADP-ribose polymerase
TLR6: Toll-like receptor 6
OVA: Allergen ovalbumin
BALF: Bronchial alveolar lavage fluids
CRP: Acute phase proteins
SSR: Signal sequence receptor
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PRP: Pattern recognition protein
SR: Scavenger receptor
MR: Mannose receptor
CR: Complement receptor
COPD: Chronic obstructive pulmonary diseases
NTHi: Haemophilus influenza
MBP: Major basic protein
EPO: Eosinophil peroxidase
EDN: Eosinophil-derived neurotoxin
H&E: Hematoxylin and eosin
Th2: T helper 2 cells
HMMs: Human monocyte macrophages
H2O2: Hydrogen peroxide
O2∙Superoxideanion
OH∙: Hydroxylradical
1O2: Singlet oxygen
MCP-1: Monocyte Chemoattractant protein 1
CCL11: Chemokine 11 or eosinophil chemotactic protein
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BMDM: Bone marrow derived macrophage
RAW 264.7: Macrophage-like, Abelson leukemia virus cells
LKR13: Murine K-ras mutant lung adenocarcinoma cell line
LPS: Lipopolysaccharide
EE: Early endosome
LE: Late endosome
Baf-A1: Bafilomycin-A1
Cyt D: Cytocholasin D
MTT: Methylthiazol Tetrazolium Assay
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Medical Technologist II at molecular diagnostic lab King Abdul-Aziz University
hospital in Jeddah
Medical Technologist II at immunology lab King Abdul-Aziz University Hospital
in Jeddah
Medical Technologist II at virology lab King Abdul-Aziz University Hospital in
Jeddah
Teaching assistant at Alqassim University from 2010 to 2015.
Lecturer at Alqassim University from 2016 currant
Vice president of women affair at university of Louisville Saudi student
association 2016.
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Vice president of women affair at university of Louisville Saudi student
association 2017.
President of Louisville Saudi student association 2018.

HONORS AND AWARDS



Award for dedication and outstanding effort as president of Saudi student
association at university of Louisville (2018-2019).



Award for dedication and outstanding effort as vice president of Saudi student
association at university of Louisville (2017-2018).



Award and recognition for valuable participation to the activities of the Saudi
association at Louisville University (2017-2018).



Award for dedication and outstanding effort as vice president of Saudi student
association at university of Louisville (2016-2017).



Best student of the year, ACCESS English program, university of Ashland,
Ashland, OH (2013-2014).



The intern of the year at King Abdul Aziz university hospital laboratories, Jeddah,
KSA (2009-2010).



Award for excellence from King Abdul-Aziz University (2007-2008).



Award for excellence from King Abdul-Aziz University (2006-2007).



Award for excellence from King Abdul-Aziz University (2005-2006).
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